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                   TolC is a versatile, multifunctional protein and in Gram-negative bacteria 
such as E.coli, it has been shown to participate in several functions like drug efflux, 
toxin secretion and has also been demonstrated to be important for survival in iron 
limiting conditions. This multifunctional nature of TolC makes it an attractive target for 
drug design and therefore it becomes imperative to understand the mechanism of TolC’s 
multifunctional nature. 
               The first part of this dissertation is focused on understanding the physiological 
function of TolC in E.coli. We found that the loss of TolC induces stress on the 
cytoplasmic membrane and notably impairs cell division and growth in minimal 
medium. The TolC-dependent phenotype was further exacerbated by the loss of ygiB 
and ygiC genes expressed in the same operon as tolC and their homologs yjfM and yjfC 
located elsewhere on the chromosome. We found that the growth deficiency of tolC 
mutants is caused by the stress on the membrane, L-serine auxotrophy, and depletion of 
essential metabolites such as GSH and NAD
+
. We conclude that disruption of 
membrane functions caused by inactivation of TolC makes cells highly vulnerable to 
the challenges of aerobic glucose metabolism. The membrane stress in ∆tolC cells leads 
to metabolic shut-down and growth arrest. The activity of YgiBC and YjfMC protects 
membranes from the stress and allows ∆tolC mutants to resume growth on glucose.  
                   The second part of this dissertation is focused on understanding how TolC 
is engaged into protein complexes.  For this purpose we constructed chromosomal TolC 
cysteine mutants with a C-terminal six histidine tag. Cysteine replacements at positions 
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Q352, D356, S363 and D374 were constructed as these residues have been predicted to 
lie at the TolC-MFP interaction interface. These chromosomal TolC cysteine mutants 
were expressed from the chromosomal native promoter and were functional. We used 
these mutants to study in vivo TolC-MFP interactions. Our co-purification and cross-
linking experiments indicate that TolC is in close association with MFP, AcrA. 
However, all the cysteine residues except for TolCQ352C were readily labeled with 
fluorescent dye, indicating that TolC is freely available for interaction with MFPs. 
These in vivo studies strongly indicate that TolC-MFP interactions are highly dynamic 






Entry and exit of molecules in all cells is tightly regulated by the permeability of the 
cytoplasmic membrane. Gram-negative bacteria like E.coli have two such membranes, 
an inner cytoplasmic membrane (IM) and an outer membrane (OM). The space between 
the two membranes is known as the periplasm. Therefore in Gram-negative bacteria 
molecules need to pass through two membrane barriers. E.coli has several different 
transporter protein complexes that facilitate this process. These complexes usually 
contain an outer membrane protein (OMP) that facilitates transport across the OM and 
an inner membrane protein which couples H
+
 transport or ATP hydrolysis to transport 
of substances.  
                       E.coli also possesses three component transport systems that allow 
transport of substances across the two membranes without periplasmic intermediates. 
This is facilitated by a third periplasmic component which forms a link to connect the 
OMP to the inner membrane transporter. Several such three component systems have 
been well studied. For example E.coli uses FepA-TonB-ExbBD transport system for 
import of colicin B and colicin D. In this system FepA is the outer membrane receptor 
whereas TonB-ExbBD forms the inner membrane-periplasmic transporter complex 
(Lazdunski et al., 1998). Similar systems such as AcrAB-TolC and MacAB-TolC are 
used for the export of an array of drugs, dyes, detergents and macrolides respectively 
(Okusu et al., 1996 and Kobayashi et al., 2001). In these three-component systems, 
AcrAB and MacAB form the inner membrane-periplasmic transporter complex and 
TolC, an outer membrane protein serves as the common exit duct. In E.coli, TolC is a  
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multifunctional export protein engaged in the efflux of xenobiotics, protein secretion 
and enterobactin export (Wandersman et al., 1990 and Bleuel et al., 2005). TolC’s 
diverse functionality stems from its ability to interact with several different transporters 
and their respective periplasmic components.  
                       The following section will highlight the known functions and structure of 
TolC. It also includes the description of the TolC-YgiBC operon as well as the 
description of glutathionylspermidine, glutathione and spermidine metabolism in E.coli. 
I.1.1 Role of TolC in multidrug resistance. Antibiotic resistance poses a major 
problem in the treatment of bacterial infections and Gram-negative bacteria tend to be 
more resistant to antimicrobials than the Gram-positive bacteria (Nikaido et al., 1998). 
The combination of the outer membrane (OM) as an additional permeability barrier and 
expression of drug resistance efflux systems makes Gram-negative bacterial infections 
difficult to treat. The genome of E.coli contains 45 predicted drug efflux transporters 
(http://www.membranetransport.org) with experimental evidence for only 14 of the 
predicted drug transporters.  To date, at least eight different multidrug transporters 
belonging to different families have been reported to require TolC for their function. 
TolC is known to interact with AcrAB, AcrD, AcrEF, MdtEF and MdtABC belonging 
to the RND (Resistance Nodulation Cell-Division) family of transporters. In addition 
TolC interacts with two MFS (Major Facilitator Superfamily) drug transport systems, 
EmrAB, EmrKY and an ABC (ATP binding cassette) drug transporter system, MacAB.  
                        AcrAB-TolC is a well-studied multidrug efflux system in E.coli. 
Inactivation of acrAB genes renders cells susceptible to an array of drugs, dyes and 
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detergents (Okusu et al., 1996). Substrates for the AcrAB-TolC pump include drugs 
such as penicillins, cephalosporins, fluoroquinolones, chloramphenicol, tetracyclines, 
novobiocin, erythromycin and rifampicin; detergents such as bile salts, sodium dodecyl 
sulfate and dyes like acriflavine and ethidium bromide (Ma et al., 1995 and Nikaido & 
Takatsuka, 2009).  AcrB is an integral inner membrane protein with 12 transmembrane 
segments (TMS) and large periplasmic loops that interact with AcrA and TolC (Seeger 
et al., 2006). AcrB determines the substrate specificity and uses proton motive force 
(PMF) to actively export its substrates. Membrane fusion protein (MFP), AcrA is 
attached to the inner membrane by lipid modification.  AcrA acts as a link between the 
inner membrane transporter AcrB and the outer membrane protein, TolC, by bringing 
them together and forming a long exit conduit (Ip et al., 2003, Zgurskaya & Nikaido, 
1999a and Zgurskaya & Nikaido, 1999). Tikhonova et al. showed that constitutively 
expressed AcrAB-TolC, irrespective of the presence of its substrate, forms a stable 
complex (Tikhonova & Zgurskaya, 2004) inside the cell (Fig I.1A). The key for the 
actual export of the substrate is opening of the TolC entrance.  It is proposed that 
conformational changes in AcrA trigger the opening of the TolC channel thus allowing 
substrates to pass through the channel. 
I.1.2 Role of TolC in virulence of pathogenic E.coli. Enterohemorrhagic and 
uropathogenic E. coli produce hemolyin toxin, HlyA which is secreted out of the cells. 
HlyA integrates into the host eukaryotic cells and forms pores causing target cell lysis 
(Stanley et al., 1998). Wandersman et.al showed that E.coli strains deficient in TolC are 
defective in secretion of hemolysin toxin (Wandersman & Delepelaire, 1990) indicating 
that TolC plays an important role in virulence of pathogenic E.coli. In E.coli HlyA is 
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expressed as a part of hlyCABD operon. Gene product of HlyC helps in posttranslational 
modification and maturation of HlyA toxin. HlyB is integral membrane protein. Its 
cytoplasmic ATP binding domain undergoes conformational change on ATP binding 
and couples ATP hydrolysis to HlyA export (Koronakis et al., 1995). HlyD is a 
membrane fusion protein (MFP) known to interact with HlyB and TolC. Cross-linking 
data shows that unlike AcrAB, HlyBD only recruits the outer membrane channel TolC 
in the presence of substrate, HlyA (Balakrishnan et al., 2001) (Fig I.1B). Thus the 
HlyBD-TolC secretion system allows direct translocation of hemolysin toxin from the 
cytoplasm to the cell surface and extracellular medium. Similar to hemolysin secretion 
TolC is also involved in secretion of colicinV, an antibacterial peptide toxin (Hwang et 
al., 1997). Colicin V secretion also requires CvaB, an inner member ABC (ATP binding 
cassette) type transporter and CvaA a membrane fusion protein which forms a link 
between CvaB and TolC. Like hemolysin toxin secretion, CvaAB-TolC complex is only 
formed in the presence of substrate colicinV (Hwang et al., 1997). 
I.1.3 Role of TolC in enterobactin secretion and other functions in E.coli. 
Enterobactin is a catecholate-type siderophore of E.coli. Enterobactin is produced and 
used for iron acquisition in iron limiting growth conditions (Bleuel et al., 2005). The 
outer membrane receptor FepA is required for the import of the Fe-enterobactin 
complex. Recently it was shown that TolC along with transporter EntS is required for 
the export of enterobactin outside the cell (Bleuel et al., 2005). These results indicate 
that TolC is important for survival of E.coli under iron limiting conditions. 
                      Recently, Wiriyathanawudhiwong et.al showed that amino acid L-
cysteine was toxic to E.coli strains deficient in TolC, indicating that the cysteine 
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toxicity could be due to the impairment of efflux of cysteine and therefore leading to 
accumulation of cysteine in the periplasm (Wiriyathanawudhiwong et al., 2009). 
                      All of the above examples exemplify the TolC’s multifunctional role in 
E.coli. The key factors for this multifunctional nature are 1) TolC structure and 2) 
ability of TolC to interact with different types of transporters.      
 
I.2 Crystal structure of TolC. TolC was crystallized as a homotrimer and the structure 
was solved at 2.1 Å resolution by Koronakis and co-workers. (Koronakis et al., 2000) 
The structure revealed TolC as a tapered long hollow cylinder 140 Å in length. It 
comprises a 40 Å long outer membrane β barrel domain (channel domain) that anchors 
a contiguous 100 Å long α-helical barrel projecting across the periplasm (tunnel 
domain) (Fig I.2A). A third domain also known as the equatorial domain is made up of 
both α-helices and β barrels and lines the mid section of the α-helical barrel. This 




The β-barrel domain.  Like majority of the bacterial outer membrane proteins (OMPs) 
that contain 8 to 22 β-sheets the channel domain of TolC is also assembled from 12 β- 
strands (four β strands from each protomer) in an antiparallel orientation  (Koronakis et 
al., 2000). The β-barrel is right twisted. Position of the amino acid residues allow for 
twisting and curving of the β-strands. Small or unbranched side chains are present 
periodically on the inside of the barrel, and residues with bulkier side chains lie on the 
outside of the barrel. The loops at the top end of the β-strands of TolC serve as partial 
external ‘lid’. These loops are highly flexible and serve as sites for colicin and 
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bacteriophage attachment (German & Misra, 2001). In most OMP the interiors are often 
partially or completely occluded however, the β-barrel of TolC is wide open and fully 
accessible to solvent. 
The α-helical domain. The α-helical barrel is contiguous with the β-barrel and extends 
into the periplasm. The α-helical domain, especially the periplasmic entrance of this 
domain, has been shown to be engaged in interaction with MFP such as AcrA 
(Lobedanz et al., 2007).  This domain comprises of 12 helices (4 from each monomer, 
an inner pair and an outer pair) in an antiparallel arrangement. Although the inner pair 
and outer pair of helices have high sequence similarity they are arranged differently. An 
inner pair of helices (H7 and H8) forms a conventional antiparallel coiled-coil but the 
outer pair (H3 and H4) comprises a straight helix (H3) around which its partner helix 4 
is coiling. All the coiled-coils are stabilized by an intermeshing of side-chains (‘knobs-
into-holes’ packing) (Fig I.3). The upper section of the helical domain (near the β-
barrel) is virtually uniform in diameter but tapers to a virtual close. One of these coiled-
coils from each monomer folds inwards at the periplasmic end and forms a constriction 
























            
 
 
Figure I.1 Recruitment of the TolC channel by AcrAB (Panel A) and HlyBD (Panel 





                       This constriction denotes the closed or resting state of TolC and has an 
effective diameter of approximately 3.9 Å (Anderson, et al., 2002) (Fig I.2B). This 
entrance has to be opened by the MFP-IM transporter to allow the export of substrates. 
This closed or resting state is stabilized by salt bridges and hydrogen bonds. Figure I. 
2D illustrates the fine network of hydrogen bonds and salt bridges. Hydrogen bonds 
between Asp153–Tyr 362 and Gln136–Glu359 connect each inner coiled coil to the 
outer coil of the same monomer. Arg367 of the neighboring monomer forms a salt 
bridge with Asp153 and hydrogen bond to Thr152, thus connecting the inner coil of one 
monomer to the outer coil of the adjacent monomer (Fig I.2D). Mutations in residues 
362 and 367 have shown TolC to remain in constitutively open state thus underlying the 
importance of H-bond network necessary for closing the periplasmic aperture  (Vaccaro 
et al., 2008)  (Augustus et al., 2004). The periplasmic entrance of the TolC channel is 
lined by a ring of six aspartic acid residues at positions 371 and 374. Previous studies 
have shown that these residues are important and can influence selection of substrates 











Figure I.2. Structural features of TolC from E.coli. Figure adapted from Andersen, et 
al., 2002. (A) TolC was crystallized as a trimer (Koronakis et al., 2000). (B) The closed 
entrance as seen from the periplasmic side. Helices of one monomer are colored. Outer 
coiled coil helices H3 and H4 are shown in green and blue, respectively. Inner coiled 
coil helices H7 and H8 are shown in yellow and red, respectively. Intramonomer (I and 
II) and intermonomer interactions (III) are shown as dotted lines. The gray background 
shows the surface representation highlighting the small periplasmic entrance. (C) The 
modeled open state of the entrance derived by realigning the inner coiled coils (H7 and 
H8) to the same configuration as the outer coiled coils (H3 and H4). (D) Intermonomer 
and intramonomer network at the tunnel entrance. Intermonomer hydrogen bonds 
between Asp153-Tyr362 and Gln136-Gln359 shown as dotted lines. Intramonomer salt 
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bridge between Arg367 of a different monomer with Asp153 shown in solid line. 











Figure I.3 Helical wheel representations of interhelical interactions of TolC α 
helical barrel. Upper and lower indicate upper and lower parts of the α helical barrel. 
Figure adapted from  Koronakis et al., 2004. 
 
I.3. The TolC-YgiBC operon. In the genome of E. coli and other enterobacteria, the 
chromosomal tolC locus contains three genes tolC, ygiB and ygiC, which are said to be 
expressed in a single operon (Fig. I.4A). However, the functions of YgiB and YgiC as 
well as any functional link between these proteins and TolC remains unknown.  
                      TolC is a member of the marA/soxS/rob regulon and contains a marbox 
consensus sequence at position 3176034–3176052 (Martin, et al., 1999). MarA, SoxS 
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and Rob are global stress induced regulators (Martin & Rosner, 2003 and Amabile-
Cuevas & Demple, 1991). Recently Zhang and co-workers showed there are four tolC 
promoters (p1-4) (Fig I.4B) (Zhang et al., 2008). Each of the promoters responds to 
different environmental signals. The p1 promoter has significant constitutive expression 
under laboratory conditions but is not responsive to EvgAS, PhoPQ, MarA, SoxS or 
Rob.  The p2 promoter is only responsive to EvgAS and PhoPQ and p3 and p4 are 
activated by MarA, SoxS and Rob (Zhang et al., 2008). Both EvgAS and PhoPQ are 
two-component signal transduction systems. EvgAS upregulates the expression of genes 
responsible for MDR phenotype (Nishino & Yamaguchi, 2001) and PhoPQ system 
responds to Mg
2+
 starvation (Kato et al., 1999). It is predicted that the presence of four 
regulatory elements responding to different environmental signals can help tailor the 













A.                                      
 
B. 
Figure I.4 E.coli TolC-YgiBC operon. A. TolC-YgiBC operon structure. B. TolC 
promoter sequences. Figure adapted from Zhang et al., 2008 
                                 
                      Kohanski et al.’s microarray data shows that expression of YgiB is 
significantly induced when cells experience oxidative stress indicating that YgiB could 
play a role in protecting E.coli cells against oxidative stress (Kohanski et al., 2007). 
YgiB is a unique protein and only shares significant homology with YjfM. YjfM is 
another protein of unknown function expressed elsewhere on the E.coli chromosome. 
YgiB is a 223 amino acid residue protein with a predicted molecular weight of 23.4 kDa 
and a pI of 9.4. YgiB is highly conserved in other bacteria such as cyanobacteria and 
proteobacteria and its homologs are also present in some Gram-positive species where 
they precede the ygiC-like genes. Amino acid sequence analysis of YgiB shows the 
presence of consensus sequence of Leu-Ala-Gly-Cys also known as the lipobox 
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(Hayashi & Wu, 1990) indicating that YgiB could be a lipoprotein. Post-translational 
modification prediction programs such as LipoP1.0 and SignalP 3.0 confirm this 
observation and predict YgiB to be an outer membrane lipoprotein containing a putative 
type II signal peptide with cleavage site between amino acid positions 36 and 37 (Fig 
I.5).  Residue at position 38, second residue after the predicted cleavage site is glutamic 
acid indicating that YgiB could be located in the outer membrane. PSIpred a secondary 
structure prediction program predicts YgiB to be an α/β type of a protein. YgiB is 
predicted to have four α-helices and five β-sheets. The predicted β-sheets have just two 
to four amino acid residues indicating that these could be small β-turns. The majority of 
the protein is predicted to be in an unstructured coil form. Another unique and striking 
feature of YgiB is the presence of four conserved cysteine residues at positions 53, 64 
88 and 97 present in α helices random coil respectively. The role of these charged 
cysteine residues in the outer membrane remains unknown but could play an important 



























Figure I.5 Secondary structure prediction of YgiB. Predicted cleavage site and 




                      YgiC is present immediately downstream of YgiB. YgiC is a 386 amino 
acid residue protein with a predicted molecular weight of 45 kDa and a pI of 4.7. YgiC 
is predicted to be a cytoplasmic protein and shares significant homology with the C-
terminal synthetase domain of E. coli GspS and an uncharacterized protein YjfC (Fig 
I.6). GspS is a bifunctional enzyme possessing both glutathionylspermidine (GSP) 
synthetase and GSP amidase activities (Bollinger et al., 1995). The C-terminal domain 
of GspS is a GSP synthetase belonging to the ATP-Grasp ATPases family of proteins, 
which also include the human glutathione synthetase (Pai et al., 2006). This domain 
uses ATP hydrolysis to conjugate glutathione (GSH) and spermidine (SPE) to yield 
glutathionylspermidine (GSP).  The crystal structure of substrate bound GspS and 
sequence alignment of YgiC with GspS shows that the residues involved in GSH and 
spermidine binding are conserved. All residues involved in binding and hydrolysis of 
ATP are also conserved in YgiC. Such high conservation of catalytically important 
residues in YgiC suggests that this protein could be a GSP synthetase. As YgiC shares 
27% identity with GspS we used crystal structure of GspS (PDB ID- 2IO9, chain B) to 
model the three dimensional structure of YgiC. Programs SWISS MODEL (Arnold et 
al., 2006, Kiefer et al., 2009 and Peitsch, 1995) and Frye (Kelley & Sternberg, 2009) 
were used for this purpose. Both programs predicted similar models, therefore the 
model generated from SWISS-MODEL was used for further analysis. Figure I.7A 
shows modeled structure of YgiC. From the predicted structure YgiC has 12 α-helices 
and 14 β-sheets. Although the overall structure looks similar to GspS synthetase domain 
there are small differences in the number and orientation of certain α-helices and β-
sheets. The presence of an additional amidase domain in GspS can account for the 
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differences in the orientation of the α-helices and β-strands. Similar to the synthetase 
domain of GpsS, the overall structure of YgiC is also triangular in shape. The N-
terminal domain of YgiC is composed mainly of α-helices and the C-terminal domain of 
β-sheets. The three main structural units conserved in human glutathione synthetase and 
GspS are also observed in YgiC even though GspS and YgiC lack any sequence 
homology with human glutathione synthetase. The three important structural features 
include an antiparallel β-sheet formed by β12 and β13. In contrast, this domain of GspS 
structure contains five β strands β 15, β 16, β 29, β 30 and β 31 form the antiparallel β-
sheet. The GSH and SPE binding sites are predicted to be centered in this antiparallel β-
sheet, in a pocket lined by α-helices 5, 6, 7. The second conserved structural feature is 
the parallel β-sheet composed of β 2, β 3, β 6 and β 7. The third structural domain is the 
lid domain and contains β 8, β 9, β 10, β 11, α-12 and the P-loop (Fig I.7A, P-loop 
indicate in Fig I.8). The ATP binding sites are predicted to be present in the anti-parallel 
β –sheet of the lid domain. High conservation in predicted structural domains of YgiC, 
similar to those of human glutathione synthetase and GspS lead us to believe that YgiC 







Figure I.6 Sequence alignment of YgiC with GspS (gsp) and YjfC. Conserved and 
similar residues are marked with *. Amino acid residues involved in GSH binding 
shown in red, ATP binding residues shown in purple, spermidine binding in green and 
residues involved in co-ordination of Mg
2+


















Figure I.7  Predicted tertiary structure of YgiC. A. SWISS-MODEL predicted 
structure of YgiC. The conserved structural domains are circled as lid domain-red, 
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antiparallel β sheet circled in black and the parallel β sheet in green. B. GspS synthetase 
domain. Figure adapted from Pai et al., 2006. The three structral domains are higlighted 











Figure I.8 Predicted YgiC structure indicating binding sites for GSH (R100, T120, 
D185, R307 and R366) and SPE (T122, E184) shown as spheres in red and green, 
respectively. Only conserved residues or residues that have conserved substitution are 
highlighted.  Predicted binding sites for ATP (K267, L284, V300, K302, G309, Q377, 
L371, I372)  and Mg
2+
 (E115) are shown in purple and blue, respectively. P-loop 
indicated in orange. 
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I.4 The YjfIJKLMC operon. YjfMC proteins share significant sequence homology 
with YgiB and YgiC, respectively. yjfMC genes are expressed as a part of an operon 
yjfIJKLMC and are present elsewhere on the E.coli chromosome (Fig I. 4A) . YjfI is a 
conserved protein 14 kDa in size with pI of 4.0. YjfJ is also a conserved protein and 
belongs to the phage shock protein A (PspA) /IM30 family of proteins and is predicted 
to be a 25 kDa protein with a pI of 6.0.  The phage shock protein (Psp) response helps 
maintain the proton motive force (PMF) in cells under PMF-dissipating stress 
conditions. YjfK is predicted to be a cytoplasmic protein with a molecular weight of 25 
kDa. YjfM is also predicted to be a cytoplasmic protein however it is 23% identical to 
YgiB, a putative outer membrane lipoprotein. Like YgiB, YjfM is a basic protein with a 
pI of 9.4. YjfC is a glutathionylspermidine synthetase homolog and is 50% identical to 
YgiC. Sequence alignment of GspS, YgiC and YjfC shows that majority of the catalytic 
residues are conserved in these proteins. YjfC like YgiC is predicted to be a 
cytoplasmic protein.  
                       tolC and ygiBC genes are predicted to constitute a single operon. 
Therefore, we hypothesized that YgiBC are functionally linked to TolC. In our research 
we tried to identify and characterize this functional link between TolC and YgiBC 
proteins. 
 
I.5. Glutathionylspermidine biosynthesis and metabolism in E. coli. 
Glutathionylspermidine (GSP) is a conjugate of glutathione (GSH) and spermidine 
(SPE). This conjugate was first detected in E.coli in 1959 by Dublin (Dubin, 1959). 
Previous studies also indicate that major fraction of spermidine is converted to GSP and 
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that GSP accumulated when E.coli is growing in glucose rich medium in stationary 
phase (Tabor & Tabor, 1975). Later this conjugate was detected in parasitic 
trypanosomas (Fairlamb et al., 1985). Fairlamb and co-workers also showed that in 
these parasitic trypanosomas, glutathionylsperimide was produced as an intermediate of 
the metabolic pathway that produces trypanothione, a bis(glutathionyl)spermidine 
conjugate (Fig I.9) (Fairlamb et al., 1985). As these parasites lack GSH reductase and 
GSH peroxidase activities, trypanothione has appropriated the role as the major and 
only antioxidant. Since trypanothione appears to have important roles in these 
pathogens and it is not present in hosts, its metabolism is an obvious target for design of 
new antiparasitic drugs. However, E.coli lacks the enzyme trypanothione synthetase and 
therefore synthesizes only GSP. The enzyme glutathionylspermidine 
synthetase/amidase (GspS) has been previously demonstrated to catalyze both the ATP 
dependent formation of an amide bond between N1 of spermidine (N-(3-amino) propyl-
1, 4-diaminobutane) and the glycine carboxylate of glutathione (γ-Glu-Cys-Gly) and the 
opposing hydrolysis of this amide bond (Bollinger et al., 1995). However its precise 
physiological role remains unclear to date. Bollinger and coworkers propose that 
conjugation of glutathione and spermidine could serve as method for modulating the 
levels of free spermidine and glutathione (Bollinger et al., 1995).  As GSP possess 
properties of both GSH and GSP it is postulated that like GSH, GSP also protects the 
cells against oxidative stress and like SPE could also stabilize/protect DNA the 
membrane. Since YgiC and YjfC share significant sequence homology with the GspS 
synthetase domain, we hypothesized that these proteins are involved in GSP 




Figure I.9 Trypanothione metabolism of Trypanosomas sp. Figure adapted from           
Kwon et al., 1997.                     
 
I.6 Spermidine metabolism in E.coli. Polyamines such as spermidine, putrescine, and 
cadavarine are polycationic molecules and are ubiquitously present in both eukaryotes 
and prokaryotes. Different cells have different concentrations and different types of 
polyamines. Prokaryotic cells have higher concentrations of putrescine than spermidine 
and completely lack spermine. In E.coli, polyamine concentrations up to 20 mM have 
been detected (Tabor et al., 1973). Tabor and coworkers showed that E.coli cells 
growing in minimal medium had 17.3 mM of putrescine and 6.3 mM of spermidine 
(Tabor et al., 1973).   
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                      Spermidine is formed by the addition of a propylamine moiety 
to putrescine. This reaction is catalyzed by enzyme aminopropyl transferase also known 
as spermidine synthetase, a speE gene product (Fig I.10). The propylamine group is 
obtained from decarboxylated S-adenosyl-L-methionine. Putrescine is formed either by 
the arginine decarboxylase via agmatine or by the ornithine decarboxylase. In E.coli 
ornithine decarboxylase is the major pathway. Intracellular concentrations of 
spermidine are tightly regulated by several feedback, recycling, and export/import 
mechanisms e.g., enzyme spermidine synthetase is feedback inhibited by its product, 
spermidine (Bowman et al., 1973). Spermidine can also be converted to other forms, 
e.g. addition of glutathione moiety to yield glutathionylspermidine. Spermidine can also 
be acetylated to give acetyl spermidine. This reaction is catalyzed by enzyme 
spermidine acetyltransferase (Fig I.10).  However the physiological roles of these forms 
of spermidine remain unknown. 
                      Polyamines have been attributed a variety of roles; however, little is 
known about their physiological role. In-vitro experiments have shown polyamines to 
be associated with membranes and have shown to protect spheroplasts from lysis, 
indicating their role in stabilizing membranes (Tabor, 1960). Igarashi and co-workers 
show that major fraction of spermidine in E.coli cells is associated with RNA (Igarashi 
& Kashiwagi, 2000). It was found that presence of polyamines stimulate the association 
of the 30S subunit of ribosome with 23S particles, thereby enhancing protein synthesis 
(Yoshida et al., 2004). Igarashi and co-workers demonstrate that polyamines stimulate 
protein synthesis by 1) changing the secondary structure of mRNA such that in the 
presence of spermidine, the Shine Dalgarno (SD) sequence and the initiation codon may 
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become closer during formation of the initiation complex, and this may be important for 
initiation e.g. structural change of OppA mRNA 2) By stimulating the interaction 
between unusual initiation codons such as UUG and the anticodon of fMet-tRNA, e.g. 
UUG–dependent fMet-tRNA binding to adenylate cyclase  mRNAribosome complex or  
3) suppression of nonsense codon by stimulation of read through of the amber codon 
UAG–dependent Gln-tRNA
supE
 on ribosome associated RpoS mRNA  (Igarashi & 
Kashiwagi, 2006). Although polyamines have been shown to enhance protein synthesis, 
stabilize membrane and DNA, polyamines are not essential for growth of E.coli as 
E.coli strains completely deficient in polyamine synthesis are able to grow but with 















I.7 Glutathione metabolism in E.coli. Glutathione (GSH), γ -L-glutamyl-L-cysteinyl-
glycine is the most abundant non-protein thiol present in all cells. GSH is present in 
both eukaryotic as well as prokaryotic cells with the exception of some eubacteria or 
archaebacteria. Intracellular concentration of glutathione ranges from 0.1 mM to 10 
mM. With its redox active cysteine thiol, GSH is the primary small molecule 
antioxidant in many cells and serves to maintain redox state of the cell and scavenge 
reactive oxygen species. In E.coli, GSH plays a critical role in protection against 
environmental stresses such as osmotic shock, oxidative stress induced by peroxides 
such as hydrogen peroxide (H2O2), protection against toxins like methylglyoxal and 
chlorine compounds like hypochlorous acid. GSH was also shown to be a negative 
regulator of the potassium channel KefB and KefC thereby regulating the cytoplasmic 
K
+
 concentrations (Masip et al., 2006).  
                       GSH is synthesized in two steps. The first step is catalyzed by γ -
glutamylcysteine synthetase (GCS), product of gshA gene that catalyzes the addition of 
glutamic acid to cysteine to form γ-glutamylcysteine. The second step is catalyzed by 
the enzyme glutathione synthetase (product of gshB gene). Glutathione synthetase 
catalyzes the addition of glycine to γ-glutamylcysteine to form GSH. Both γ -
glutamylcysteine synthetase and glutathione synthetase are cytosolic ATP dependant 
enzymes (Fig I.11).  Intracellular concentrations of GSH are tightly regulated by 
feedback inhibition of biosynthesis, degradation and oxidation to its dimeric disulfide 
form GSSG. The enzyme γ -glutamylcysteine synthetase is regulated by feedback 
inhibition by product GSH. Because of its unique γ linkage, GSH cannot be degraded 
easily and only one peptidase, γ -glutamyl transpeptidase, is known to degrade GSH. 
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Surprisingly, this enzyme is localized to the periplasmic space, therefore, degradation of 
GSH takes place only in the periplasm. However, the transporter protein responsible for 
transport of GSH from cytoplasm to periplasm is still unknown. The ratio of oxidized 
and reduced GSH is maintained by glutathione reductase (the product of the gor gene) 
which uses reducing equivalents from NADPH to convert oxidized form of GSH 
(GSSG) to GSH. Thus, glutathione reductase serves as the key link between the two 
redox couples (GSH/GSSG and NAD(P)H/NAD(P)) in the cell. 





I.8 Aims and Scope of this Dissertation. TolC is required for survival of E.coli under 
conditions that induce stress in cells and its multifunctional nature of TolC makes it an 
attractive target for designing inhibitors to block the TolC channel.  Therefore 
understanding the mechanism of TolC’s interaction with different classes of 
transporters, the mechanism of export of small molecules like drugs and large protein 
peptides, and identifying other physiological substrates exported by this channel is 
necessary.  The main goal of this research is to understand the physiological function of 
TolC in E.coli. In order to achieve this goal we aimed to 1) identify and establish a 
functional link between TolC and YgiB, YgiC and 2) identify proteins interacting with 
















II. Experimental Procedures 
 
II.1 Construction of Strains. Strains with deletions in tolC, ygiBC and yjfMC (ygiBC 
homologues) genes were made by the method described by Datsenko and Warner, 2000. 
All the deletion strains are derivatives of WT, BW25113 strain (lacI
q
 rrnBT14 ∆lacZWJ16 
hsdR514 ∆araBADAH33 ∆rhaBADLD78). This method uses lambda recombinase system 
to insert a kanamycin resistance gene in the desired locus thus disrupting the gene of 
interest. Antibiotic resistance genes were removed as described in (Datsenko & 
Wanner, 2000). All the deletion strains were confirmed with PCR (Appendix A). 
JW0117-1 (∆speE), JW2914-1 (∆gshB), JW2956-1 (∆gspS), JW2663 (∆gshA) strains 
are derivatives of WT, BW25113 strain. These strains were obtained from the Keio 
collection (Coli, genetic stock centre, Yale University). These strains were also 
confirmed with PCR. 
II.2 Growth curves and growth rates. Growth rates were measured in Luria-Bertani 
(LB) medium (10 g of Bactotryptone, 10 g of yeast extract, and 5 g of NaCl per liter) 
and M9 minimal medium(5X M9 salts (Difco), 0.4% glucose, 2 mM MgSO4 and 0.1 
mM CaCl2). Overnight grown cultures were diluted 1:100 into a fresh medium. The 
change in cell mass was monitored by measuring the optical density (600 nm) of the 
cultures every hour. The growth rates were calculated as the slope of the graph (lnOD600 
vs. time (hr)) in exponential phase of growth. Time points corresponding to both lag 
phase and stationary phase were not included in growth rate calculations. The parent 
BW25113 (WT) strain was included as a positive control. For experiments related to 
nutrient deficiencies, strains were grown in M9 medium supplemented with 0.4% 
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casamino acids or 0.4% glycerol, xylose and fructose. Strains were also grown in M9 
medium supplemented with either of the following amino acids or vitamins : 0.2 g/L L-
aspartic acid, 0.6g/L L-glutamic acid, 0.1 g/L L-serine, 0.2 g/L L-methionine, 0.2 g/L 
L-glycine, 0.1 g/L L-cysteine, 1 mg/L thiamine or 1mg/L riboflavin. For growth curves 
in LB medium supplemented with glutathione, cells were grown overnight in LB 
medium and then diluted 1:100 in fresh LB medium supplemented with 5 mM, 10 mM 
and 15 mM glutathione (reduced) (Sigma). 
II.3 Phase contrast and fluorescence microscopy. E. coli strains were grown 
overnight in LB medium and diluted 1:100 into fresh M9 medium and grown at 37°C 
for twenty hours. One microlitre of culture was spread onto a slide and a coverslip was 
placed on the top. The slides were viewed and photographed with Spot (Insight) camera 
mounted onto an Olympus BX50 microscope. For fluorescence microscopy, the WT 
strain along with all deletion strains was grown in M9 medium. Aliquots of the growing 
cultures were taken at 0.3 OD600, and fixed in PBS/ethanol solution by
 
mixing 400 µl of 
cell culture with 6.6 ml of ice-cold
 
PBS/ethanol (70%). Cells were washed
 
once with 
PBS, and resuspended in 400 µl of PBS. Poly-lysine (25µg/ml) was added to the cells. 
The cells were spread on to clean cover slips and incubated for 5-10 minutes. The 
excess fluid was washed off. 15 µl of 1x Sypro
 
Orange stain and 100 nM of DAPI (4',6'-
diamidino-2-phenylindole) was added onto the cover slip, and viewed with UPlan F1 
objective lens on Olympus BX50 microscope. 
II.4 SDS-PAGE and immunoblotting. Denaturing SDS-PAGE was performed by 
standard methods using 12% separating gels. Samples were boiled with 4X sample 
buffer supplemented with β-mercaptoethanol and loaded onto SDS-PAGE gel. For 
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immunoblotting analyses, the proteins were transferred onto polyvinylidene difluoride 
membranes (PVDF) in buffer containing 250 mM Tris-Cl (pH not adjusted) 192 mM 
glycine and 10% methanol. Transfer was carried out at 70V for 1 hr. The membranes 
were then stored in blocking buffer (5% dry milk) at 4°C. The membranes were washed 
and incubated with rabbit primary antibody (Anti-TolC, Anti-AcrA or Anti-AcrB 
antibody) for 1 hr, washed and then incubated with the secondary anti-rabbit antibody 
conjugated to alkaline phosphatase (Sigma). Protein bands were visualized by substrates 
5-bromo-4-choloro-3-indoyl phosphate and nitro blue tetrazolium.  
II.5 Protein Expression Profiles. Strains were grown at 37ºC in 50 ml M9 medium. 
Cells were collected by centrifugation in exponential phase (0.6 OD600) and stationary 
phase (48 h after inoculation into fresh M9 medium). Cells were washed and then 
resuspended in 10 mM Tris-HCl (pH 8.0) and 5 mM EDTA buffer and treated with 
lysozyme for 40 min. Sonication was used to lyse cells. Unbroken cells were removed 
by low speed centrifugation and membranes were collected by ultracentrifugation for 
1hr at 100,000 ×g Beckman centrifuge (Optima TLX Ultracentrifuge). The membrane 
pellet was resuspended in buffer containing 50 mM Tris-HCl (pH 8.0), 0.1 M NaCl and 
1 mM PMSF. Twenty micrograms of cytoplasmic and membrane proteins were 
analyzed on 12% SDS PA gels and Coomassie Brilliant Blue staining. Total protein 
concentration was estimated using the Bradford assay with BSA as a standard. 
II.6 Stationary phase viability. Overnight grown cultures were re-inoculated into fresh 
M9 medium. These cultures were allowed to grow for 10 days. For strains requiring 
ampicillin, M9 medium was supplemented with 100 µg/ml carbenicillin. Aliquots of the 
growing cultures were taken at 0 hr, 3 days, 6 days and 10 days. At every time point the 
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optical density of the culture was measured. The cultures were diluted appropriately and 




) per culture were 
used to plate and 2 plates per dilution were used. After incubation at 37°C the colonies 
were counted. 
II.7 Norfloxacin killing assay. The method was followed as described previously by 
Kohanski et al., 2007. Briefly, strains were grown overnight in LB medium, diluted 
1:1000 into fresh LB medium. The cells were grown up to 0.3 OD600. Bactericidal 
antibiotic norfloxacin (in DMSO) was added at different concentrations (100 ng/ml, 250 
ng/ml, and 600 ng/ml). After every hour the optical density of the culture was measured 
and 100 µl of aliquot was removed, washed twice with fresh LB medium, diluted 
appropriately and plated onto LB plates. After incubation at 37°C colonies were 
counted. 
II.8 Hydrogen peroxide disk diffusion assay. All cultures were grown overnight in 
LB medium. 100 µl of overnight grown cultures were plated onto LB plates. 5%, 15% 
and 30% of H2O2 were used. 4 filter paper disks were placed onto each plate. 20 µl of 
the above H2O2 solutions were added to each of these disks. As a control 20 µl of water 
was added to fourth disk. After incubating the plates overnight at 37°C, diameters of 
clearing zones were measured. 
II.9 Reverse Transcriptase PCR (RT-PCR). RT-PCR was performed by using 
QIAGEN OneStep RT-PCR kit. Total RNA was isolated from exponentially growing 
cells (LB medium) using QIAGEN RNeasy kit. RNA prep was digested with DNase I 
to digest contaminating DNA. 2 µg of purified total RNA were used for RT-PCR. To 
detect the tolC transcript (reaction 4 in Fig. III.1B), the forward primer tolCstart and the 
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reverse primer TolCS2 were used to yield a product of 1173 bp (Lane 4 and 5). To 
detect the ygiB and ygiC mRNA (reactions 1, 2, and 3 on Fig III.1B) the forward primer 
TolCD1 and the reverse primers (1) rygiBRT, (2) rygiBRT #2 and (3) rygiCRT were 
used to yield products of 889 bp, 1184 bp and 1810 bp, respectively. 
II.10 Sucrose density gradient fractionation. Cells were grown in 100 ml LB medium 
supplemented with 100µg/ml ampicillin to an OD600 of 0.6. EDTA-lysozyme treatment 
was performed to prepare spheroplasts (Osborn et al., 1972 and Tikhonova & 
Zgurskaya, 2004). These spheroplasts were sonicated on ice for 45s. Unbroken cells 
were removed by centrifugation. Membrane vesicles were collected by 
ultracentrifugation at 60,000 rpm for 1 h in a Beckman 70Ti rotor. The membrane pellet 
obtained was resuspended by water bath sonication in buffer containing 20% sucrose 
and 5 mM EDTA. This membrane fraction was loaded onto a 2 step sucrose gradient 
(60% and 25%) and centrifuged in a 70-Ti rotor at 40,000 rpm for 3.5 h. Both the outer 
and inner membrane fractions were collected together, diluted and centrifuged at 40,000 
rpm for 40 min to pellet total membranes. Membrane pellet was resuspended and loaded 
onto a 5 step sucrose gradient (30%, 35%, 40%, 45%, 50%, 55% and 60%) and 
centrifuged at 40,000 rpm for 12 hr. 250 µl fractions were collected from the bottom of 
the gradient. The samples were boiled and analyzed by 12 % sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (PAGE) and visualized by silver staining. 
II.11 Minimum Inhibitory Concentration (MIC) measurements. MIC of various 
antimicrobial agents was measured in 96 well plates (Tikhonova et al., 2004). 
Approximately 10
4
 exponentially growing cells were inoculated in LB medium 
supplemented with two-fold increasing concentrations of a drug. In case of MIC 
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measurements in the presence of glutathione, cells were inoculated into LB medium 
supplemented with a drug and 15 mM, 10 mM or 5 mM concentration of reduced 
glutathione.  
II.12 Determination of intracellular thiol content. HPLC was used to analyze 
monobromobimane (MBB) derivatized thiols (Helbig et al., 2008 and Fairlamb et al., 
1986). Cells growing in LB medium (OD600 ~ 1.0) were collected by centrifugation and 
either resuspended in the same volume of fresh LB or washed and then resuspended in 
fresh M9. Cells were incubated at 37°C with shaking (220 rpm) and were collected by 
centrifugation at one, twelve and twenty hours post reinoculation. Approximately 10
9
 
cells were washed with fresh M9 medium and resuspended in buffer containing 40 mM 
HEPES-KOH (pH 7.0) and 5 mM EDTA. 
                       Derivatization with MBB (73.7 μM final concentration) was carried out 
at 70°C for 3 min. The samples were cooled briefly on ice. The reaction was stopped by 
adding equal volume of 4 M lithium methanesulfonic acid and further incubated for 30 
min. HPLC analyses were done on a Zorbax C-18 column (Hewlett Packard) and 
Shimadzu LC-10Ai HPLC system with RF-10AXL fluorescence detector. The 
fluorescence of MBB derivatized thiols was detected at 380 nm excitation and 490 nm 
emission wavelengths. Mobile phase A contained 0.25% (w/v) d-camphorsulfonate in 
water, pH 2.7. Mobile phase B contained 0.25% (w/v) d-camphorsulfonate and 25% 
isopropanol. 
II.13 GSSG reductase recycling assay for GSH and GSSG measurements.  
Procedure was similar to that used by Aslund F, 1999 and Anderson M., 1985. Cells 
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were grown as described above. Approximately 10
9
 cells growing in LB/M9 medium 
were resuspended in 20 µl of 143 mM sodium phosphate/6.3 mM EDTA, pH 7.4 and 10 
µl of 10% 5-sulfosalicylic acid. Samples were centrifuged at 13,000 rpm for 5 min to 
remove protein precipitates. The assay volume was scaled down to 300 µl. 210 µl 
NADPH (0.25 mg/ml) and 30 µl 5-5'-dithiobis(2-nitrobenzoic acid) (DTNB) were 
incubated at 30°C for 15 min and then 60 µl of sample and 3 µl of 266U/ml yeast 
glutathione reductase enzyme (Sigma) were added to the reaction mix to start the 
reaction. For GSSG measurements 20 µl of supernatant was treated with 0.4 µl of 2-
vinylpyridine. The pH of the reaction was adjusted to 6-7 by adding triethanolamine. 
Rate of change of absorbance at 412 nm was monitored for 5 min. The assay was 
calibrated with GSH and GSSG standards using concentrations between 0.15 nmoles 
and 1.2 nmoles. The same reactions were set to measure GSH and GSSG in culture 
supernatants, except 25 μl of each supernatant were used in the reaction. 
II.14 NAD
+
 and NADH measurements. Procedure was similar to that used in Dwyer 
et al., 2007. Briefly, ~5X10
9
 cells were taken from cultures growing in LB/M9 medium.  
Samples were centrifuged at 15,700×g for 2 min and the cell pellets were frozen in dry 
ice ethanol bath and stored at -80°C until use. 250 µl of 0.2 M NaOH (for NADH 
extraction) or 250 µl of 0.2 M HCl (for NAD
+ 
extraction) was added to the ice-cold 
pellets.  Samples were boiled for 10 minutes and then centrifuged at 9,300×g for 5 min.  
The NAD
+
/NADH supernatants were immediately used for assay.  The assay reaction 
mix consisted of 30 µl 1.0 M BICINE-NaOH (pH8.0), 75 µl sample extract, 75 µl 0.1 
M NaOH for NAD samples and 0.1 M HCl for NADH samples, 30 µl 16.6 mM 
phenazine ethosulfate, 30 µl 4.2 mM 3-[4,5-dimethylthiazol-2-yl]-2,5-
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diphenyltetrazolium bromide (MTT), 30 µl absolute ethanol and 30 µl 40 mM EDTA 
(pH 8.0). The reaction mix was pre-incubated for 3 minutes at room temperature and 6 
µl of 500 U/ml yeast alcohol dehydrogenase (Sigma) enzyme was added to start the 
reaction. The rate of reduction of MTT was monitored at 570 nm for 5 min. The rate of 
reduction of MTT is directly proportional to NAD
+
/NADH (Dwyer et al., 2007 and 
Matsumura & Miyachi, 1980). NAD
+
 and NADH standards (Sigma) between 0.125 
nmoles and 1.25 nmoles were used to calibrate the assay. 
II.15 Construction of chromosomal TolC cysteine mutant strains. TolC mutants 
containing a single cysteine substitution in positions Q352, D356, S363, D374 and a six 
histidine tag at the C-terminus were constructed previously by  Bobyk and Zgurskaya 
(unpublished). TolC WT and its Cys-containing derivatives were expressed from a 
pTrc99a based plasmid.  
                      In order to express WT TolC and TolC cysteine mutants from the E.coli 
chromosome, we first used these plasmids as templates to generate a PCR product for 
electroporation. Forward primer ftolCstart, containing a sequence homologous to TolC 
start sequence and reverse primer rtolChis2, containing a sequence homologous to the 
YgiC downstream sequence was used to generate PCR product. Next the PCR product 
was cleaned using a PCR clean-up kit. This PCR product was then treated with 
restriction enzyme DpnI to digest template plasmid. After digestion the PCR products 
were concentrated to ~100 ng/µl using Zymoclean PCR clean up kit. This PCR product 
was transformed into GD102 strain (∆tolC∆ygiBC::kan). Colonies with correct 
insertion were selected by growing on LB plates containing 32µg/ml novobiocin 
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followed by confirmation with PCR. After PCR confirmation all TolC cysteine mutants 
as well as TolC
his
 insertions were confirmed by sequencing.  
                     AcrAB deletions in the above mentioned chromosomally expressed TolC 
cysteine mutants were constructed by first transforming the strains with pKD46 plasmid 
followed by electroporation of kanamycin gene PCR products into these strains. This 
PCR product was generated by using pKD4 as template plasmid and primers 
fAcrABKandisrup and rAcrABKandisrup. 
II.16 In vivo whole cell labeling with F5M (fluoresceine-5-malemide). All TolC 
cysteine mutants along with WT (BW25113) strain as positive control and GD102 
strain as negative control were grown until ~1.0 OD600  in 50 ml LB medium. Cells were 
washed with PBS buffer and then resuspended in 1.5 ml PBS. Freshly made 
fluoresceine-5-malemide was added to a final concentration of 250 µM, and incubated 
for 30 min at 4°C on the rotator (Dastidar et al., 2007). 1 mM DTT was added to stop 
the reaction and incubated for 1 min on ice. After centrifugation the pellet was 
resuspended in 1.5 ml buffer (10 mM Tris-HCl (pH 8.0), 5 mM EDTA). To lyse the 
cells 100 µg/ml lysozyme was added and incubated for 40 min on ice. Sonication was 
used to break the cells. Unbroken cells were pelleted and the supernatant was 
centrifuged at 100,000 ×g for 1 hr to pellet the membranes. The membrane pellet was 
resuspended in 100 µl buffer (50 mM Tris-HCl (pH 8.0), 100 mM NaCl and 1 mM 
PMSF). Water bath sonicaton was used to get a homogenized membrane fraction. 
Protein concentration was measured using Bradford assay (Bio-Rad) with BSA as 
standard. 20 µg of total protein was loaded onto 12% SDS-PA gel. The gel was scanned 
on a Storm 840 phosphor imager and fluorescent screen imaging system (Amersham 
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Pharmacia-Molecular Dynamics) and then stained with Coomassie Brilliant Blue stain 
to visualize protein bands. 





 strain was grown in LB medium to an OD600 1.2. Cells were 
washed twice with buffer (20 mM sodium phosphate pH 7.5, 150 mM sodium chloride 
and 1 mM EDTA), concentrated 7.5 times and incubated 30 min at RT with either 
DMSO (control) or SPDP. The reaction was stopped with 2.5 mM Tris-HCl (pH 7.4). 
Cells were centrifuged and washed in buffer containing 0.75 M sucrose, 10 mM Tris-
HCl (pH 8.0) and resuspended in 35 ml of the above buffer. Spheroplasts were prepared 
by adding 100 µg/ml lysozyme and slowly adding 70 ml of 1.5 mM EDTA (pH 8.0) (on 
ice). Spheroplasts were fragmented into membrane vesicles by sonication for 60-90 sec. 
Low speed centrifugation was done to remove unbroken cells followed by 
ultracentrifugation at 100,000 ×g for 1.5 hr to pellet membrane vesicles. Membrane 
pellet was resuspended in 2 ml buffer containing 0.25 M sucrose, 3.3 mM Tris-HCl (pH 
8.0) and 1 mM EDTA (pH 8.0) loaded onto a 2 step sucrose gradient (1.44 M, 0.77 M 
sucrose) and centrifuged at 100,000 ×g for 4 hr. The outer membrane pellet was 
resuspended and solubilized in binding buffer (50 mM Tris-HCl (pH 8.0), 500 mM 
NaCl, 1 mM PMSF, 5 mM imidazole) supplemented with 5% Triton X-100. Insoluble 
material was removed by centrifugation at 100,000 ×g for 40 min. The soluble fraction 
was incubated for 2 hr at RT with Cu
2+
 charged His bind resin (Novagen) equilibrated 
in binding buffer and 0.2% Triton X-100. TolC
his
 was purified by washing column with 
20 column volumes of binding buffer supplemented with 5 mM Imidazole, 10 column 
volumes of binding buffer containing 50 mM Imidazole, 10 column volumes of binding 
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buffer  with 60 mM Imidazole, then washed twice with half column volumes of binding 
buffer containing 500 mM Imidazole. 500 mM imidazole fractions were concentrated 
with 10% TCA (trichlotoacetic acid). All fractions were analyzed by SDS-PAGE and 
western blot analysis using anti-AcrA, anti-AcrB and anti-TolC antibodies.  
II.18 Real Time CPM uptake assay. Overnight grown cultures were diluted 1:100 into 
fresh LB medium and grown to 0.6 OD600. Cells were washed with buffer (50 mM 
potassium phosphate pH 7.0, 1 mM magnesium sulfate, and 0.5% glucose. Cells were 
resuspended into appropriate volumes so as to achieve 3.0 OD600, diluted to 0.1-0.2 
OD600 just before the start of the experiment. 1-5 µM 7-Diethylamino-3-(4'-
maleimidylphenyl)-4-methylcoumarin (CPM, dissolved in DMSO, λabs=384 nm, 
λem=469 nm) concentrations used. Fluorescence was measured on a Shimadzu RF 5301-
PC spectroflurometer with a slit width 5.0. 
II.19.Colicin secretion assay. Respective strains were transformed with pHK11 
carrying cvaABC and cvi genes (Gilson et al., 1990). The colicin sensitive strain 
BW25113 was grown in LB medium for about 12-14 hr. 100 µl of this culture was 
spread onto to LB agar plates. With the help of wooden sticks a single colony of strains 
transformed with pHK11 plasmid were spotted onto these plates. The plates were 
incubated overnight at 37°C. Diameters of zone of clearing (no cell growth) were 
measured the next day. 
II.20 LIVE/DEAD cell assay. Molecular probes LIVE/DEAD BacLight Bacterial 
Viability kit was used to score live and dead cells. Cells growing in LB (OD600 ~ 1.0) 
were collected by centrifugation and either resuspended in the same volume of fresh LB 
or washed and then re-suspended in fresh M9. Cells were incubated at 37°C with 
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shaking (220 rpm) and were collected by centrifugation at one, twelve and twenty hours 
post re-inoculation. Cells from 2.5 ml of culture were resuspended in 200 µl 0.85% 
NaCl. 100 µl of this suspension was added to two tubes containing 2 ml of 0.85% NaCl 
(for live cells) and as a control to 2 ml of 70% isopropanol (for killed cells). Both the 
samples were incubated at room temperature for one hour with gentle mixing every 15 
minutes. Cells were centrifuged at 10,000 ×g, 4°C for 10 min, washed twice with 0.85% 
NaCl and finally resuspended in 1 ml 0.85% NaCl. For microscopy, equal volumes of 
SYTO 9 dye solution (3.3 mM) (as provided in the kit) and propidium iodide (20 mM) 
(as provided in the kit) were mixed. 0.3 µl of this dye mixture was added to 100 µl of 
cell suspension and incubated for 15 minutes in the dark at room temperature. 5 µl of 
the stained bacteria were trapped between a slide and a cover slip, observed and 
photographed with the help of a Spot (Insight) camera mounted onto an Olympus BX50 
microscope through an UPlanF1 X 100/1.3 oil-immersion objective. 
II.21 NADH oxidase assay. Cell membrane preparation and the NADH oxidase assay 
were performed as described before (Tikhonova & Zgurskaya, 2004). Briefly, Cells 
growing in LB (OD600 ~ 1.0) were collected by centrifugation and either resuspended in 
the same volume of fresh LB or washed and then re-suspended in fresh M9. Cells were 
incubated at 37°C with shaking (220 rpm) and were collected by centrifugation at one, 
twelve and twenty hours post re-inoculation. Disruption of cells by EDTA-lysozyme 
treatment was performed as described previously (Osborn et al., 1972). Sonication was 
used to lyse cells. Unbroken cells were removed by low speed centrifugation and 
membranes were collected by ultracentrifugation for 1 hr at 100,000×g. The membrane 
pellet was resuspended in 10 mM Tris-HCl (pH 8.0), 0.25 M sucrose. Protein 
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concentration of total membrane was measure using Bradford assay with BSA as a 
standard. 50 µg total protein was used for the assay. The assay mixture contained 50 
mM Tris-HCl-Cl (pH 7.5), 0.3 mM DTT and 0.60 µM NADH (Sigma). Rate of 




















III.1 Inactivation of TolC induces stress on E.coli membrane and 
arrests growth on glucose. 
III.1.1 tolC, ygiB and ygiC genes are expressed as a part of the same operon. In 
order to check and establish a functional link between TolC and YgiBC we first wanted 
to confirm that tolC, ygiB and ygiC genes constitute a single operon. For this purpose 
we used reverse transcriptase PCR (RT-PCR). Total RNA was extracted and purified 
from E.coli BW25113 (WT) cells using QIAGEN RNeasy kit. RT-PCR reactions using 
forward primer annealing to tolC locus and reverse primer annealing either to ygiB or 
ygiC locus were set up (Fig III.1B lanes 1, 2 and 3). A positive control reaction using 
forward and reverse primers annealing to the tolC was set up (Fig III.1B lane 4). 
Another control reaction without any reverse transcriptase was also set up to rule out 
possible DNA contamination (Fig III.1B lane 5). Figure III.1B shows that expected 
PCR products of sizes 889 bp, 1173 bp, 1184 bp and 1810 bp  were obtained only in 
reactions where reverse transcriptase was present, indicating no DNA contamination in 
total RNA extracts and confirming that tolC, ygiB and ygiC genes are transcribed 
together.  
III.1.2 Deletion of ygiBC genes does not affect TolC expression.  To investigate the 
function of ygiB and ygiC genes in E.coli, we created a series of chromosomal deletion 
mutants. Chromosomal gene deletions were made using the lambda red recombinase 
system as described by Datsenko & Wanner, 2000. Kanamycin resistance gene 
insertions into the desired loci were confirmed with PCR. To create strains with two or  
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more gene deletions, the kanamycin resistance gene was first excised by transforming 
the strain with pCP20. PCR using primers specific to upstream and downstream regions 
of the deleted gene was done to confirm that the kanamycin resistance marker was 
successfully excised. Following confirmation, the same technique of lambda red 
recombination was used for insertional inactivation of the second locus, thus yielding a 
strain with two chromosomal gene deletions. A similar strategy was used if more 
deletions were desired. Kanamycin resistance marker was removed from tolC and 
ygiBC locus. Description of all strains created including genotype and PCR 
confirmations are listed in Appendix A.  
                      yjfM and yjfC are close homologues of ygiB and ygiC genes respectively 
and could have similar functions as ygiBC. Therefore, we made a combination of 
deletion strains where only yjfMC genes were deleted, yjfMC and ygiBC were deleted 
and a third strain where tolC-ygiBC were deleted together with yjfMC genes. 
 
 Figure III.1 TolC is expressed along with YgiBC. A. TolC operon with primer 
positions indicated. B. RT-PCR analysis of RNA isolated from E. coli BW25113 (WT) 
strain. The same RNA sample was used in all reactions. Lanes 1-3: RT-PCR reactions 
with forward and reverse primers that anneal to tolC-ygiBC transcript (primers 1, 2 and 
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3 in panel A). Lane 4: RT-PCR reaction using forward and reverse primers that anneal 
to tolC transcript (primers 4, 5 in panel A). Lane 5 is the same reaction as in lane 4 but 
RT was omitted (no DNA control). 
                        
                     We next wanted to test if ygiBC genes are involved in regulation of 
expression or assembly of TolC. Membrane fractions were isolated from WT, ∆tolC and 
∆ygiBC strains. Membrane proteins were separated using 12% SDS-PAGE and then 
transferred onto PVDF membranes. These membranes were then probed with anti-TolC 
antibodies. Immunoblotting analysis (Figure III.2) shows the same level of TolC 
expression and trimerization in ∆ygiBC strains as compared to WT, indicating that 
YgiBC are not required for TolC expression or assembly.  
 




Figure III.2 Deletion of ygiBC genes does not affect TolC expression. 
Immunoblotting analysis of TolC in WT (BW25113), ∆tolC (GD100) and ∆ygiBC 
(GD101) strains. 20 µg of total membrane proteins were separated on 12% SDS-PA gel. 
TolC was visualized using polyclonal anti-TolC antibody. + sign indicates boiled 
samples and – sign indicates unboiled samples.  
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III.1.3 Deletion of YgiBC does not affect TolC multidrug resistance (MDR) 
function. In order to establish a functional link between TolC and YgiBC, we wanted to 
check if YgiBC proteins participate along with TolC to confer MDR to E.coli cells. For 
this, we measured drug susceptibilities of WT, ∆tolC, ∆ygiBC and ∆yjfMC strains. The 
MIC data showed that, as expected, all the ∆tolC strains were highly susceptible to 
drugs and the detergent SDS. The ∆ygiBC and ∆ygiBC-yjfMC strains showed similar 
levels of resistance for norfloxacin and SDS but showed two-fold increased resistance 
for erythromycin and four-fold higher resistance for novobiocin as compared to WT 
(Table 1a). ∆yjfMC strain showed two-fold increased resistance to novobiocin and 
erythromycin and was equally susceptible to norfloxacin and SDS as compared to WT. 
Both erythromycin and novobiocin are bacteriostatic antibiotics which have different 
targets in the cell. Novobiocin binds to DNA gyrase inhibiting DNA replication 
whereas erythromycin binds to the 70S subunit of the ribosome thereby halting protein 
synthesis.  
                        As ∆ygiBC strains showed increased levels of resistance for novobiocin 
and erythromycin we also measured MIC’s of other substrates of the TolC dependant 
efflux pumps (Tikhonova & Zgurskaya, 2004). WT and ∆tolC strains were included as 
positive and negative controls respectively. MIC results show that ∆ygiBC strains show 
the same level of resistance as WT for all drugs tested (Table 1b). These results indicate 






Table 1a: MIC (µg/ml) measurements of WT and mutant strains. 
Strain Genotype ERY NOV NOR SDS 
BW25113 WT 32 32 0.04 >10240 
GD100 ΔtolC 1 1 0.01 5 
GD101 ΔygiBC 64 128 0.04 >10240 
GD102 ΔtolC ΔygiBC 1 1 0.0025 5 
GD103 ΔyjfMC 64 64 0.04 >10240 




1 0.25 0.005 5 
GD106 ΔspeE ΔtolC 1 1 0.005 5 




64 32 0.01 >10240 
GD109 ΔspeE ΔygiBC ND ND ND ND 
    GD110     ∆speE, ∆gshB ND ND ND ND 
GD111 ΔyjfMC ΔtolC ND ND ND ND 
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  ERY-Erythromycin, NOV- Novobiocin, NOR- Norfloxacin, SDS- sodium dodecyl 
sulfate. ND-not determined. Values in bold in this table and all other tables indicate that 
these are significantly different from the WT values. 
 








Cholic Acid >10000 1250 >10000 
Ethidium bromide 200 1.5625 200 
Oleandomycin 625 4.88 625 
Puromycin 32 1 32 
Cinoxacin 0.975 0.488 0.975 
Nalidixic acid 1.56 0.195 1.56 
GD112 ΔgshA ΔtolC 1 1 0.0025 5 
  JW0117-1          ∆speE 32 64 0.02 >10240 
  JW2914-1          ∆gshB 64 256 0.04 >10240 
  JW2956-1          ∆gspS 64 64 0.02 >10240 
  JW2663-1           ∆gshA ND ND ND ND 
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Chloramphenicol 1.6 0.2 1.6 
Tetracycline 0.312 0.078 0.312 
Chlortetracycline 0.39 0.049 0.39 
Lincomycin 312.5 39 312.5 
 
III.1.4 ∆TolC strains have severe growth defects when grown in M9 medium. To 
understand the function of ygiB and ygiC genes we investigated the growth phenotypes 
of WT, ∆tolC, ∆ygiBC and ∆tolC-ygiBC strains. In Luria-Bertani (LB) medium all the 
strains had growth patterns and growth rates similar to WT (Figure III.3A). However, in 
M9 medium ∆tolC strain grew with a rate of 0.4 hr
-1
, approximately 1.5 times slower 
than WT and showed a delay of growth close to 5 hours before it resumed growth 
(Figure III.4A). Unlike ∆tolC strain, ∆ygiBC strain grew with rates similar to WT and 
∆tolC-ygiBC strain had growth phenotype similar to that of ∆tolC strain.  
                    The above mentioned strains along with ∆ yjfMC, ∆ ygiBC-yjfMC, ∆ tolC-
ygiBC-yjfMC strains and WT as a control were grown in LB and M9 medium. As 
observed previously in LB medium all strains had growth rates similar to that of WT 
(Figure III.3B). In M9 medium ∆ yjfMC strain grew with rates similar to WT 
suggesting that YgiBC and YjfMC could have reciprocal functions (Figure III.4A). ∆ 
ygiBC-yjfMC strain also had growth rates comparable to those of WT (Figure III.4A). 
However when tolC was deleted in combination with ygiBC and yjfMC the growth 








































was twice lower than WT (Figure III.4A) (Table 2). Therefore these results suggest 
YgiBC and YjfMC have complimentary functions and that both TolC and YgiBC or 
YjfMC are required for normal growth of E.coli in glucose minimal medium.                  




                                         





Figure III.3: Growth curves in LB medium. A) Growth curves of WT and ∆ygiBC 
strains. B) Growth curves of ∆yjfMC strains. Growth rates (hr
-1
) are calculated as slope 
of individual graphs. GD100 (∆tolC), GD101 (∆ygiBC) GD102 (∆tolC∆ygiBC) GD103 
(∆yjfMC), GD104 (∆ygiBC∆yjfMC) and GD105 (∆tolC-∆ygiBC∆yjfMC). 
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       A. 




        B. 








Figure III.4:  Growth curves in M9 medium. A) Growth curves of GD100 (∆tolC), 
GD101 (∆ygiBC) GD102 (∆tolC∆ygiBC) GD103 (∆yjfMC), GD104 (∆ygiBC∆yjfMC) 
and GD105 (∆tolC∆ygiBC∆yjfMC) strains. B) Growth curves of ∆speE, ∆gshB and 









                     YgiC and YjfC share significant homology with glutathionylspermidine 
synthetase (GspS) and therefore could be involved in glutathionylspermidine synthesis. 
We reasoned that the long lag phases and slower growth rates observed in ∆tolC, 
∆tolC-ygiBC and ∆tolC-ygiBC-yjfMC strains could be due to the deficiency of 
glutathionylspermidine and TolC in the cells. To test this hypothesis we requested 
∆speE (spermidine synthetase), ∆gshB (glutathione synthetase), ∆gshA (γ-glutamate-
cysteine ligase) and ∆gspS strains from the Keio collection (Baba et al., 2006). 
Spermidine synthetase is the last enzyme involved in spermidine biosynthesis; 
therefore ∆speE strains do not produce any spermidine in the cells. Similarly GshB 
synthesizes glutathione (GSH) by ligating precursor γ-glutamyl-cysteine with glycine. 
∆gshB strains do not produce GSH but accumulate the precursor γ-glutamyl-cysteine 
(Helbig et al., 2008). GshA is the penultimate enzyme of glutathione biosynthesis 
pathway. ∆gshA strains neither produce the precursor γ-glutamyl-cysteine nor GSH 
(Helbig et al., 2008). GspS is a well characterized glutathionylspermidine 
synthetase/amidase.  
                      TolC was deleted in these strains after excising the kanamycin resistance 
marker from the speE, gshB and gshA locus. We also constructed an E.coli strain 
lacking the two putative glutathionylspermidine synthetases, ygiBC and yjfMC and the 
well characterized glutathionylspermidine synthetase/amidase, GspS (GD108).  
                      The above mentioned strains were grown in glucose minimal medium 
(Figure III.4B). ∆speE, ∆gshB and ∆gspS strains had growth rates slightly lower than 






















exhibited phenotypes similar to TolC
-
 strains. These strains demonstrated a lag of 
growth of approximately three hours and their growth rates ~0.4 hr
-1 
were similar to 
TolC
-
 strains. ΔygiBCΔyjfMCΔgspS, a strain completely lacking 
glutathionylspermidine showed no defect when growing in glucose minimal medium 
and grew at rates similar to those of WT (Figure III.4C, Table 2).  These results 
strongly suggest that the growth defects observed in ∆tolC-ygiBC-yjfMC strain is not 
due to the lack of GSH, SPE or GSP.  
                      Next we wanted to check if the growth defects observed in ∆tolC strains 
can be rescued by expression of TolC. For this purpose we transformed GD100 
(∆tolC), GD102 (∆tolC-ygiBC) and GD105 (∆tolC-ygiBC-yjfMC) strains with a 
plasmid expressing TolC (pTolC
his
). Expression of TolC alone could completely rescue 
the growth defects observed in GD105 strain (Figure III.5) (Appendix B) thus 
confirming that TolC and ygiBC, yjfMC have parallel independent functions. 





Figure III.5: TolC complements the phenotype observed in M9 medium. Growth 





Table 2: Growth rates (hr
-1
) of WT and deletion mutants in LB and M9 medium. 
Strain name Genotype Growth rate (hr
-1
) 













1.22 ±0.13  0.62 ± 0.05 
GD100  ΔtolC 1.12 ±0.08  0.44 ± 0.05 
GD101  ΔygiBC 1.14 ± 0.18  0.63 ± 0.01 
GD102  ΔtolC ΔygiBC 1.04 ±0.003 0.55 ±0.05 
GD103 ΔyjfMC 1.17 ±0.04 0.62 ±0.07 
GD104  ΔygiBC ΔyjfMC 1.03 ±0.01 0.65 ±0.03 
GD105 ΔtolC ΔygiBC 
ΔyjfMC 
1.11 ± 0.03 0.34 ±0.1 
GD106 ΔspeE ΔtolC ND 0.49 ± 0.06 
GD107 ΔgshB ΔtolC ND 0.52 ± 0.06 
GD108 ΔygiBC ΔyjfMC 
ΔgspS 
ND 0.58 ± 0.03 
GD109 ΔspeE ΔygiBC ND 0.61 ± 0.02 
GD110 ∆speE, ∆gshB ND 0.57 ± 0.04 
GD111 ΔyjfMC ΔtolC ND 0.43 ± 0.08 
GD112 ΔgshA ΔtolC ND 0.52 ± 0.04 
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JW0117-1 ∆speE ND 0.52 ±0.04 
JW2914-1 ∆gshB ND 0.57 ±0.04 
JW2956-1 ∆gspS ND 0.55 ±0.04 
JW2663-1 ∆gshA ND 0.58 
AG100AX K-12 argE3 thi-1  





1.0 ± 0.05 ND 
W4680 K-12  ∆acrAB::kan ND 0.63±0.007 
W4680AE K-12 ∆acrAB::kan 
∆acrEF::spe 
ND 0.52 ± 0.01 
ZK4 MC4100 ND 0.7 ± 0.05 
ZK796 MC4100 but  
∆tolC::tet 
ND 0.74 ± 0.001 
ECM2112 
 
MC4100 but  
∆acrAB::kan  
∆tolC::tet 
ND 0.53 ± 0.02 
ND- Not determined. Except otherwise noted, all strains are derivatives of BW25113 
(WT). 
III.1.5 L-serine can rescue the growth defects observed in M9 medium. Above 
results show that ∆TolC strains are unable to grow in M9 medium but grow similar to 
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WT in LB medium. M9 medium is a chemically defined medium containing glucose as 
carbon source, ammonium, phosphate and sulfate salts as a source of nitrogen, 
phosphorus and sulfur, respectively. Cells obtain energy by breaking down glucose via 
glycolysis and tricarboxylic acid cycle (TCA), generating reducing equivalents and 
important intermediates for amino acid, nucleotide and vitamin biosynthesis. In 
contrast, LB is a complex medium containing yeast extract, sodium chloride and 
tryptone. Yeast extract and tryptone provides cells with an abundant supply of 
vitamins, amino acids, pyruvate and other intermediates of amino acid and nucleotide 
metabolism. Cells use this supply of amino acids and vitamins and generate energy 
through gluconeogenesis.  Therefore, when growing in LB and M9 medium cells 
utilize two different pathways to generate energy. We reasoned that the growth defects 
observed in M9 medium could be due to a nutrient deficiency caused by inhibition or 
halt of a biosynthetic pathway.                                                                     
                              To further investigate the growth defect observed in ∆tolC strains, these 
strains were grown in M9 medium supplemented with 0.4% casamino acids (Figure 
III.6A). Casamino acids are casein hydrolysates containing a majority of vitamins, 
trace elements and all amino acids with the exception of glutamine, aspargine and 
proline. The presence of casamino acids in M9 medium restored normal growth of all 
∆tolC strains suggesting that the defect in growth could be due to the deficiency of 
certain vitamins and/or amino acids (Figure III.6A, Appendix B).   
                      To further identify the essential vitamin/amino acid we grew these strains 
in M9 medium supplemented with either 1 mg/ml riboflavin or 1 mg/ml thiamine. 
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Riboflavin serves as a precursor for the formation of flavin nucleotides which in turn 
serve as prosthetic groups for several oxido-reductase enzymes (Sauer et al., 1996) 
Thiamine is an important co-factor required by several enzymes involved in glycolysis 
and TCA cycle. Riboflavin and thiamine were not able to restore normal growth in 
∆tolC strains suggesting that this growth defect could be due to an amino acid 
deficiency (Figure III.6B) (Appendix B).  
                       Next, we tested different amino acids. These amino acids were chosen 
based on: 1) If they serve as precursors for the biosynthesis of GSH and spermidine 2) 
If they serve as precursors for biosynthesis of other amino acids. WT and GD105 strain 
were grown in M9 medium supplemented with either 0.2 g/L L-aspartate, 0.6 g/L L-
glutamate or 0.1 g/L L-serine. L- aspartate serves as a precursor for L-aspargine, L-
methionine, L-lysine and L-threonine, which in-turn serves as a precursor for L-
isoleucine. L-glutamine, L-proline, L-arginine are synthesized from L-glutamate and 
L-serine is an intermediate of the L-cysteine and L-glycine biosynthetic pathway. 
GD105 strain growing in M9 medium supplemented with L-glutamate or L-aspartate 
did show an increase in growth rate; however, it still had a lag phase of approximately 
6 hours (Figure III.6B, Appendix B). Only L-serine was able to completely recue the 
growth defects of GD105 strain. In the presence of L-serine, GD105 strain resumed 
growth immediately without a lag phase of 9 hours and growth rate of GD105 strain 
was similar to WT (Figure III.6C) (Appendix B). Since glycine and cysteine are 
synthesized from serine we next tested if one of these amino acids could restore normal 
growth of GD105 strain. Neither glycine nor cysteine was able to rescue growth 
defects in GD105 strain. In presence of glycine, GD105 strain still showed a lag phase 
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of 8-9 hours (Figure III.6C) and consistent with previous results 
(Wiriyathanawudhiwong et al., 2009) cysteine was toxic, to even WT cells. Taken 
together these results suggest than GD100 and GD105 strains when growing in M9 
medium with glucose as carbon source develop an auxotrophy for L-serine.  
III.1.6 ∆TolC strains are unable to efficiently metabolize glucose.  The next 
question that we wanted to address was if this growth defect was specific only when 
glucose is used a carbon source. Therefore we grew WT, GD100 and GD105 in M9 
medium with 0.4 % glycerol as the sole carbon source. In E.coli, glucose is mainly 
transported by the phosphoenolpyruvate phosphotransferase system (PTS) (Meadow et 
al., 1990). As it enters the cell, glucose is immediately phosphorylated to glucose 6-
phosphate. Glucose 6-phosphate is subsequently oxidized to pyruvate via glycolysis. 
Glycerol is transported by GlpF a transporter belonging to the aquaporin channel 
family of proteins (Stroud et al., 2003). Once inside, glycerol is rapidly phosphorylated 
by glycerol kinase to produce glycerol 3-phosphate. Glycerol 3-phosphate is further 
oxidized to dihydroxyacetone phosphate by glycerol 3-phosphate dehydrogenase with 
the reduction of FAD to FADH2. Dihydroxyacetone phosphate enters the glycolytic 
pathway and the reducing equivalents of FADH2 are transferred ultimately to oxygen 
through the electron transport chain  (Lin, 1976). Surprisingly, in M9 + glycerol 
medium both GD100 and GD105 strains showed WT phenotype (Figure III.7A, 
Appendix B). Cells grew with rates equivalent to that of WT and no lag phase was 
observed.  These differences in growth phenotypes suggest that the defects observed 
when strains are growing in medium with glucose as carbon source could be either due 
to a defect in transport of glucose into the cells or due to inhibition of enzymes 
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involved in the early stage of glycolysis namely phosphofructokinase, 
phosphoglucoseisomerase and aldolase. We, next used M9 medium supplemented with 
0.4% fructose (Figure III.7B, Appendix B) or 0.4% xylose (Figure III.7C, Appendix B) 
as carbon source to grow WT, GD100 and GD105 strains. Like glucose, fructose is 
transported into the cells in a PTS dependent manner  (Meadow et al., 1990). Once 
inside the cells fructose is phosphorylated to fructose 1- phosphate and fructose 6- 
phosphate , which then enters the glycolysis pathway.  E.coli cells express a xylose 
specific ABC transporter, XylFGH to import xylose  (Song & Park, 1998). Growth 
curve experiments show that fructose was also able to restore normal growth of GD100 
and GD105 strains (Figure III.7B). No lag was observed and the growth rates were 
similar to those of WT. Xylose was unable to completely restore normal growth in 
GD100 and GD105 strains (Figure III.7C). Although growth rates of both GD100 and 
GD105 strains were similar to those of WT strain, GD100 strain still showed a lag 
phase of ~6 hours and GD105 strain showed a lag phase ~1 hour. Taken together these 
results suggest that glucose metabolism and not uptake of glucose is affected in 
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Figure III.6: L-serine in growth medium rescues the defects observed in ∆tolC-
ygiBC-yjfMC strains. A.  Growth curves of WT and ∆tolC strains in M9 medium 
supplemented with 0.4% casamino acids. B. Growth rates in M9 medium supplemented 
with amino acids. C. Growth curves in M9 medium supplemented with 0.1g/L serine 
and 0.2g/L L-glycine.         
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Figure III.7: ∆TolC cells are unable to efficiently metabolize glucose. A: Growth 
curves of WT, GD100 (∆tolC) and GD105 (∆tolC-ygiBC-yjfMC) strains in M9 medium 
supplemented with 0.4% glycerol. B: Growth curves of WT, GD100 (∆tolC) and 
GD105 (∆tolC-ygiBC-yjfMC) strains in M9 medium supplemented with 0.4% fructose. 
C: Growth curves of WT, GD100 (∆tolC) and GD105 (∆tolC-ygiBC-yjfMC) strains in 
M9 medium supplemented with 0.4% xylose. 
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III.1.7 ∆TolC cells are filamentous and have anucleate cells in M9 medium. It was 
shown previously that ∆tolC strains growing in M9 medium are filamentous and 
produce anucleate cells (Hiraga et al., 1989). To check this, WT, GD100, GD101, 
GD102, GD103 and GD105 cells were grown in M9 medium for 12 hours. An aliquot 
of this culture was spread on to glass slides. The slides were viewed with a 100X phase 
contrast objective lens. Microscopic observations show that GD101 (ygiBC), GD103 
(yjfMC) and GD104 (ygiBC-yjfMC) strains are similar to WT. However GD100 
(tolC), GD102 (tolC-ygiBC) and GD105 (tolC- ygiBC-yjfMC) cells are more 
elongated than WT (Figure III.8A).  
                        To check if chromosomes were properly segregated in GD100, GD102 
and GD105 strains exponentially growing cells in M9 medium were fixed and stained 
with DAPI and SYPRO orange. SYPRO-orange stains the cell membranes and 
nucleoids were stained with DAPI. Fluorescence microscopy images show that 
consistent with previous results ∆tolC strains show anucleate cells (Figure III.8B, 
marked with arrows). Population of anucleate cells reduced significantly when these 
strains are transformed with plasmid expressing TolC, suggesting that this defect is 
specific to loss of tolC and that TolC is required for normal chromosomal segregation.  
Figure III.8A. ∆tolC cells are more elongated than WT when growing in M9 
medium. Phase contrast microscopy to determine cell shape and size. 
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                WT                                      GD100                                GD101 
       
              GD102                                     GD103                               GD104 
        
            GD105                           GD100/pTolC
his
                        GD102/pTolC
his
 
       
Figure III. 8B. Fluorescence microscopy of DAPI and SYPRO orange stained 
cells. The Nucleoids stained with DAPI are shown in pink and the SYPRO orange 
stained cell membranes are shown in blue. Adobe Photoshop was used to generate 
colored images. Anucleate cells in ∆tolC strains are marked with an arrow. 
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III.1.8 ∆TolC strains when grown in M9 medium overproduce membrane protein 
PspA in stationary phase. We determined protein expression profiles of cells grown 
in LB and M9 medium in 1) Exponential phase 2) Stationary phase. No significant 
differences were observed in both membrane and cytoplasmic fractions when strains 
were grown in LB medium. Significant differences were observed in membrane 
protein expression patterns of ∆TolC strains grown in M9 medium. Membrane 
fractions of ∆TolC strains showed the expression of two unique proteins of molecular 
weight 27 kDa and 44 kDa (Figure III.9). To gain further insight into the localization 
of these two proteins, differential solubilization in 1% Sarkosyl was done for one hour 
on ice. Inner membrane proteins are solubilized with 1% Sarkosyl; however, outer 
membrane proteins remain insoluble in 1% Sarkosyl (Filip et al., 1973). The soluble 
and insoluble fractions can then be easily separated by centrifugation at 100,000 ×g for 
an hour. The 27 kDa protein was readily soluble in 1% Sarkosyl indicating to be an 
associated/integral inner membrane protein. In contrast the 44 kDa protein remained 
insoluble in 1% Sarkosyl and therefore was identified as an outer membrane protein. 
The N-terminal sequencing identified the 27 kDa protein to be Phage shock protein A 
(PspA). PspA expression is induced when E.coli is subject to extracytoplamic stress 
which leads to dissipation of the proton motive force (Kobayashi et al., 2007).  
However N-terminal sequencing could not identify the 44 kDa protein. We think that 
as the 44 kDa is localized in the outer membrane it could be modified at its N-terminal 
thereby blocking its sequencing. 
                      Our results described above show that presence of serine or other carbon 
sources such as glycerol and fructose in the growth medium could relieve the defects 
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observed in ∆TolC strains. Therefore, we wanted to check if membrane damage is 
caused by growth conditions or if it’s caused by deletion of TolC. WT and GD105 
strains were grown in M9 medium supplemented with serine or 0.4% glycerol for 48 
hours. Membrane protein expression profiles show that when growing in the presence 
of serine or glycerol GD105 strain still overproduced PspA (Figure III.10). These 








Figure III.9: ∆TolC strains overproduce PspA in stationary phase. All strains were 
grown in M9 medium and harvested at 0.6 OD600 for exponential phase and after 48 hr 
for stationary phase samples. Panels A and C represent cytoplasmic protein profiles in 
exponential and stationary phase, respectively. Panels B and D represent membrane 
protein profiles in exponential and stationary phase, respectively. In all panels: Lane 1- 
WT, Lane 2- ∆tolC (GD100), Lane 3-  ∆ygiBC (GD101), Lane 4- ∆tolC-ygiBC 
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(GD102), Lane 5- ∆yjfMC (GD103), Lane 6- ∆ ygiBC-yjfMC (GD104), Lane 7- ∆tolC-
ygiBC-yjfMC (GD105). PspA, the 27 kDa protein indicated in a box.  
Figure III.10. GD105 (∆tolC-ygiBC-yjfMC) strain overproduces PspA when grown 
in M9 medium supplemented with L-serine (Panel A) and Glycerol (Panel B) for 48 
h (stationary phase). 20 µg of cytoplasmic fractions (Lanes 1, 2) and membrane 
fractions (Lanes 3, 4) loaded onto 12% SDS-PA gel and stained with Coomasie Brilliant 
Blue stain.   
III.1.9 Deletion of TolC does not affect viability of cells growing in M9 medium. 
Induction of PspA expression is a strong indication of stress conditions in the cell. 
Therefore we wanted to check if the viability of ∆TolC strains is affected under these 
conditions. WT, ∆tolC (GD100), ∆ygiBC (GD101), ∆tolC-ygiBC(GD102), 
∆yjfMC(GD103), ∆ygiBC-yjfMC(GD104), ∆tolC-ygiBC-yjfMC(GD105), ∆speE (JW0117) 





 plasmid were used as positive controls. All the strains were grown for 10 
days at 37°C with shaking. An aliquot of the growing cultures was removed at 0, 3, 6 
and 10 days. At every time point optical density of the culture was measured, culture 
was diluted accordingly and plated onto LB-agar plates.  The graphs represent the 
number of colony forming units normalized to optical density of the culture plotted 
against time of incubation. ∆ygiBC, ∆yjfMC, ∆ygiBC-yjfMC and ∆speE strains are similar 
to WT (Figure III.11A and B). Highest number of viable cells was present when cells 
were in exponential phase (0 day) and there was a decrease in viable cell count as 
incubation time increased. The only significant difference between the viable cell 
count of ∆TolC strains and WT is during the exponential growth phase. Both ∆tolC 
and ∆tolC-ygiBC-yjfMC strains had ~100-150-fold less number of viable cells at 0 day 
time point. However at 10 days these strains had similar numbers of viable cells as 
WT. The three ∆tolC strains transformed with pTolC plasmid showed similar patterns 
as WT. These results confirm that deletion of TolC causes the cells to grow slower, 
































































A.                                                                 B. 
Figure III.11A: Deletion of TolC does not affect cell viability. Panel A: Cell viability 
profiles of WT and ∆ygiBC strains growing in M9 medium. Panel B: Cell viability 
profiles of WT, ∆tolC strains and ∆tolC strains transformed with pTolC plasmid 
growing in M9 medium. 
                       Next, we also used the LIVE/DEAD BacLight stain kit (Invitrogen) to 
determine the number of live cells and the extent of membrane stress in the stationary 
ΔtolC cells. This kit combines nucleic acid stains SYTO9 and propidium iodine. 
Propidium iodide has been shown to be excluded from cells with structurally intact 
cytoplasmic membranes because of the size and charge of the propidium molecule 
(Boulos et al., 1999). As shown on Fig. III.11C, during LB-to-M9 transition and in the 
stationary phase the vast majority of WT and ΔtolC mutant cells remain alive. For all 
strains, we found that the number of dead cells is less than 5% and remains the same in 
the exponential and stationary phases.  
                       The results of this experiment are in agreement with the results of 
determination of colony forming units in the stationary WT and ΔtolC mutants. Both 
these experiments confirmed that in stasis ΔtolC cells have the same survival frequency 
as the WT. However, GD100 and GD105 cells when grown in M9 were notably longer 
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than the WT cells indicative of cell division defects (Fig. III. 8A, B). Thus, ΔtolC cells 
survive membrane stress and metabolic problems they experience upon transition into 
the stationary phase in M9 medium. These results further confirm that extended lags 
and slow growth rates of ∆tolC cells upon re-inoculation into a fresh medium (Fig. 
III.4) are not caused by the low number of live cells but most likely result from the loss 
























































Figure III. 11C. The LIVE/DEAD Bacterial viability kit was used to score live and 





III.2 Understanding the physiological role of E.coli TolC-YgiBC 
operon.  
III.2.1 ∆TolC strains have low concentrations of NADH and NAD
+
 when growing 
in M9 medium. Our results indicate that the growth defects observed in ∆TolC strains 
are specific when glucose is used as carbon source. Therefore, we next measured the 
NADH, NAD
+
 concentrations in cells. NADH and NAD
+
 concentrations are strictly 
regulated and high NADH/NAD
+
 ratios inhibit pyruvate dehydrogenase, citrate 
synthase and α-ketoglutarate dehydrogenase, the key enzymes of TCA cycle (Prüss et 
al., 1994).  TCA cycle converts pyruvate to oxaloacetate with the simultaneous 
conversion of NAD
+
 to NADH. The reducing equivalents of NADH are then finally 
transferred to electron transport chain to produce ATP (Voet & Voet, 1996). TCA cycle 
also produces intermediates for amino acid and nucleotide biosynthesis. We 
hypothesized that ∆TolC strains have high NADH/NAD
+
 ratio therefore are unable to 
grow in M9 medium. We used the NAD
+
 cycling assay to measure NADH and NAD
+
 
concentrations during the LB-M9 transition and in the stationary phase (Leonardo et al., 
1996). WT and mutants growing in LB medium had ~ 1 mM concentration of NAD
+
 
(Table 3a). Even in stationary phase WT and ∆tolC cells maintained 1 mM of NAD
+
, 
but in ∆tolC-ygiBC-yjfMC cells the concentration of NAD
+
 decreased to 0.3 mM.  
                        All strains contained similar concentrations of NAD
+
 one hour after the 
shift into M9 medium (Table 3a). As incubation time in M9 increased NAD
+
 
concentration dropped significantly in ∆tolC-ygiBC-yjfMC cells.  Extension of stasis for 
20 hours led to three-fold drop to 0.3 mM of NAD
+




concentration further decreased to 0.08 mM in ∆tolC-ygiBC-yjfMC cells. These results 
suggest that when growing in M9, ∆tolC cells and ∆tolC-ygiBC-yjfMC cells cannot 
efficiently synthesize NAD
+
, which eventually leads to depletion of this cofactor in the 
stationary phase.  
                      When growing in LB, exponential and stationary phase ∆tolC-ygiBC-
yjfMC cells contained twice higher concentrations of NADH than WT. High 
concentrations suggests that ∆tolC-ygiBC-yjfMC cells are unable to synthesize amino 
acids (Prüss et al., 1994). In case of WT, amounts of NADH increased in the M9 12 
and 20 hr samples. This increase in NADH concentration reflects the decrease in 
respiration rate and results in starvation in the stationary phase. However, the amounts 
of NADH did not change significantly in ∆tolC and ∆tolC-ygiBC-yjfMC cells. Due to 
depletion of NAD
+
 and the concentration of NADH being constant in ∆tolC-ygiBC-
yjfMC cells, the NADH/NAD
+
 ratio was almost three in M9 20 hr samples as opposed 
to a NADH/NAD
+
  ratio of one in the M9 20 hr samples of WT and ∆tolC cells. This 
result strongly suggests that in M9 medium, ∆tolC-ygiBC-yjfMC strain is not only 
deficient in biosynthetic activities but cannot oxidize NADH as well. As YgiC and 
YjfC are close homologs of glutathionylspermidine we measured concentrations of 
NAD
+
 and NADH in ∆gshA cells that do not synthesize GSH (Helbig et al., 2008) 
(Table 3a). The amounts of NAD
+
, NADH and the NADH/NAD
+
 ratio are very similar 
in gshA and WT cells, indicating that the lack of GSH and GSP did not cause the 
metabolic problems in ∆tolC-ygiBC-yjfMC cells.  
                        NAD
+
 depletion in the stationary phase ∆tolC-ygiBC-yjfMC cells could 
be completely rescued by plasmid expressing TolC (Table 3b) suggesting that TolC 
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alone is required to maintain normal metabolism in E.coli. In agreement TolC
+
 cells 
lacking ygiBC and yjfMC genes had normal NADH/NAD
+
 ratios.  
                     Taken together these results strongly suggest that during stationary phase 
tolC cells are depleted of essential metabolites. This metabolite depletion is notably 
accelerated in ∆tolC-ygiBC-yjfMC cells. The high NADH/NAD
+
 ratio in the stationary 
phase cells of ∆tolC-ygiBC-yjfMC strain indicates that the metabolic shutdown in these 
cells is caused by depletion of NAD
+
. 
 III.2.2. NADH dehydrogenases are inhibited in ΔtolC cells. During aerobic 
metabolism, the major pool of NADH is re-oxidized on the membrane by two 
membrane-bound NADH dehydrogenases NDH-I and NDH-II (Yun et al., 2005). Thus, 
either one or both of these proteins could be inhibited in GD105 cells. To further 
confirm this conclusion we measured the NADH oxidase activity in membrane fractions 
isolated from WT and ΔtolC mutants grown in LB and M9 media. We found that the 
exponential WT and mutant cells contained similar levels of the membrane bound 
NADH oxidase activity (Table 4). In the stationary WT and GD100 cells, the NADH 
oxidase activity decreased by 25-35%. In contrast, the NADH oxidase activity of 
GD105 membranes dropped 2-3-fold when cells entered stasis in either medium and 
was 40-60% lower than in the stationary WT cells. Thus, in accord with NADH/NAD
+
 
measurements (Table 4), GD105 membranes cannot efficiently oxidize NADH. We 
conclude that inhibition of membrane-bound NADH dehydrogenases contributes to 








    Table 3a. NAD
+
 and NADH concentrations in WT and ∆tolC mutants. 
   
Medium
, time of 
incubati
on 












































































































































 and NADH concentrations in ∆ygiBC-yjfMC (GD104) and ∆ tolC 
ygiBC-yjfMC/pTolC (GD105/pTolC) mutants. 
 
Table 4. NADH oxidase specific activity (U/mg) in membranes isolated from WT 



































LB, 1 hr 1.7±0.03 0.97±0.04 0.6 1.51±0.01 1.1±0.01 0.7 
LB, 12 hr 0.43±0.01 0.21±0.07 0.5 0.52±0.05 0.26 
±0.05 
0.5 
M9, 1 hr 1.5±0.1 0.25±0.07 0.2 1.2±0.1 0.3±0.003 0.3 
M9, 12 hr 1.1±0.14 0.5±0.007 0.4 0.99±0.01 0.51±0.06 0.5 
M9, 20 hr 0.52±0.00
07 
0.36±0.01 0.7 0.6±0.05 0.51±0.01 0.8 
Medium,  
time of incubation 
WT GD100 GD105 JW2663 
LB, 1 hr 0.39 ± 0.06  0.46 ± 0.09 0.39 ± 0.03 ND 
LB, 12 hr 0.28 ± 0.02 0.28 ± 0.04 0.13 ± 0.01 ND 
M9, 1 hr 0.49 ± 0.09 0.33 ± 0.04 0.52 ± 0.1 0.25 ± 0.02 
M9,  12 hr 0.31 ± 0.1  0.36 ± 0.05 0.21 ± 0.01 0.45 ± 0.09 




III.2.3 ∆TolC strains have lower concentrations of intracellular glutathione than 
WT when growing in M9 medium. As ygiC and yjfC share close sequence homology 
with glutathionylspermidine synthetase we hypothesized that the lack of these putative 
enzymes will lead to a decrease in the levels of GSP in cells. To determine GSH and 
GSP concentrations in ∆tolC, ∆tolC- ygiBC-yjfMC strains, we derivitized cell extracts 
with a thiol specific dye monobromobimane (MBB) (Fairlamb et.al., 1986 and Fahey & 
Newton, 1987). MBB reacts with thiols to give a fluorescent bimane adduct with an 
excitation wavelength of 380 nm and emission wavelength of 490 nm. These derivitized 
extracts were separated by a reverse phase C-18 column and the peaks were detected 
with a fluorescence detector. WT and ∆gshA strains were included as positive and 
negative controls, respectively. As the growth defects observed in these strains were 
more pronounced during exit of stationary phase when cells were transferred from LB 
to M9 medium we wanted to monitor GSH and GSP levels during LB-M9 shift. 
Aliquots of samples were removed and derivitized when cells were growing for one and 
twelve hours in LB medium and one, twelve and twenty hours after transfer to fresh M9 
medium. GSH and GSP standards were derivitized using the same procedure as that 
used for other samples.  
                        HPLC profiles show the presence of 4 peaks (Figure III.12). The early 
peak at 52 min is present all samples including the control samples with dye only, 
indicating that this peak is a non-specific product which originates from the dye. 
Comparing GSH standard graphs, the 58 min peak represents GSH as this peak is not 




present in ∆gshA samples indicating that these peaks are non-GSH linked peaks (Figure 
III.12).  
                      Cells grown for one hour in LB medium have similar levels of 
intracellular glutathione ~6 mM (Table 5). In case of strains growing for twelve hours 
in LB medium, WT and ∆tolC cells have ~5 mM GSH whereas ∆tolC- ygiBC-yjfMC 
strain contains ~3 mM intracellular GSH. An hour after incubation in fresh M9 
medium GSH concentrations remained constant at approximately 7 mM level in WT 
and ∆tolC cells but GSH levels in ∆tolC- ygiBC-yjfMC cells decreased further. Twelve 
hours after shift into M9 medium, GSH concentrations in WT and ∆tolC strain 
remained high, but GSH concentrations in ∆tolC- ygiBC-yjfMC strain decreased further 
to 1.7 mM. Twenty hours of incubation in M9 medium led to the complete drop of 
GSH below detection limits in both ∆tolC and ∆tolC- ygiBC-yjfMC cells. In conclusion 
these results indicate that loss of TolC leads to depletion of the intracellular GSH 
concentration in stationary phase. 
                       Reasons for the drop of intracellular glutathione concentrations in ∆tolC 
and ∆tolC-ygiBC-yjfMC cells after incubation for twenty hours in M9 could either be 
due to inhibition of GSH biosynthesis or the oxidization of GSH to GSSG.  A drawback 
of the HPLC technique is that MBB can derivitize only reduced thiols therefore GSSG 
cannot be detected unless the samples are pretreated prior to derivitization. To 
overcome this problem we used the glutathione reductase assay which measures the 
total glutathione (GSH+GSSG) in cells (Anderson, 1985). Consistent with HPLC 
studies, WT cells maintained ~8-10 mM total GSH when incubated in LB medium for 




mM when these cells were further incubated for twelve and twenty hours in M9 
medium. ∆tolC cells show similar levels of [GSH+GSSG] when grown in LB medium 
and when incubated for one hour in fresh M9 medium. However [GSH+GSSG] 
drastically decreases to 1.8 mM when cells are incubated for twenty hours in M9 
medium (Table 6). In contrast ∆tolC-ygiBC-yjfMC cells after transfer to M9 medium 
showed decreasing levels of [GSH+GSSG] as the incubation time increased from one to 
twenty hours.  
                     GSSG concentration in all cells was ~1 M. Such low concentration of 
GSSG cannot account for the dramatic drop of GSH in ∆tolC strains. This result 
strongly suggests that the depletion of GSH in GD100 and GD105 strains, probably 





Figure III.12:  The M9 grown ΔtolC cells deplete endogenous GSH. Intracellular 
glutathione concentrations in WT, ∆tolC (GD100), ∆tolC-ygiBC-yjfMC (GD105) and 
∆gshA (JW2663) strains were detected using HPLC and MBB labeling. Glutathione 
(GSH) and glutathionylspermidine (GSP) standards shown in JW2663 panel. The 
intracellular concentrations of GSH when detectable were calculated from peak area 






























LB, 1 h 6.3 5.5 5.5 ND 
LB, 12 h 4.9 4.5 4.5 ND 
M9, 1 h 7.3 6.8 6.8 ND 
M9, 12 h 18.2 6.2 6.2 ND 




















 ND-Not determined. – below detection limits. 
 
Medium,  
time of incubation 
WT GD100 (∆tolC) GD105(∆tolC-ygiBC yjfMC) 
GSH+GSSG, mM GSH+GSSG, mM GSH+GSSG, mM 
in out in out in out 
LB, 1 h 10.4±0.1 ND 9.7±0.8 ND 7.6±1.9 ND 
LB, 12 h 8.1±0.4 ND 8.3±0.01 ND 7.8±1.2 ND 
M9, 1 h 8.8±0.7 - 7.1±0.3 - 4.2±0.3 - 
M9, 12 h 17.7±1.9 0.001± 0.0002 8.5±0.1 0.008 ±0.0003 2.4±0.2 0.009 ± 0.001 




III.2.4 Extracellular glutathione is toxic to ∆TolC strains. Our HPLC profiles show 
that tolC and tolC-ygiBC have very low concentrations of GSH in the stationary 
phase. Furthermore results of GSSG-GSH recycling assay suggest that the biosynthesis 
of GSH may be affected. To check if the growth defects of tolC strains observed in 
M9 medium are due to the complete lack of GSH in these strains we grew WT, tolC 
and tolC-ygiB-yjfMC strains in M9 medium supplemented with 2 mM GSH. Growth 
curves in figure III.13A show that the presence of 2 mM GSH in the medium was not 
able to rescue tolC and tolC-ygiB-yjfMC strains from the growth defects observed in 
M9 medium. These results suggest that low concentration of GSH is not the sole reason 
for the observed growth defects (Appendix B). However, we also tested 5 mM, 10 mM 
and 15 mM concentrations of GSH. Surprisingly 15 mM GSH was toxic to tolC and 
tolC-ygiB-yjfMC strains even in LB medium. tolC and tolC-ygiBC-yjfMC strains 
show different levels of tolerance towards extracellular GSH concentrations. In LB 
medium supplemented with 10 mM GSH tolC-ygiB-yjfMC already showed a two-fold 
decrease in growth rate as compared to WT. Although growth rates of WT strain also 
decreased from 1.0 hr
-1 
in LB medium to 0.7 hr
-1 
in LB medium supplemented with 15 
mM GSH, high concentrations of GSH were well tolerated by WT strains (Appendix B) 
(Figure III.13B).  
                       Previously it was reported that TolC is involved in cysteine tolerance and 
that tolC strains are highly susceptible to 10 mM cysteine (Wiriyathanawudhiwong et 
al., 2009). Therefore to check if GSH toxicity was due to cysteine we grew WT, tolC 
and tolC-ygiB-yjfMC strains in LB medium supplemented with 1 mM and 5 mM of 




similar to WT suggesting that the toxicity of high concentrations of GSH was not due to 
cysteine but due to the lack of tolC, ygiBC and yjfMC gene products.   
 
A.                                                             B. 
 
C.                                                                D. 
Figure III.13 Extracellular glutathione is toxic to ∆ TolC strains : A: M9 + 2 mM 
GSH   B: WT growth curves in LB medium with 5 mM, 10 mM and 15 mM GSH. C: 
GD100 growth curves in LB medium with 5 mM, 10 mM and 15 mM GSH. D. GD105 
growth curves in LB medium with 5 mM, 10 mM and 15 mM GSH 
 
III.2.5 YgiBC and YjfMC do not contribute significantly towards protection 
against norfloxacin and hydrogen peroxide (H2O2). Previously it was demonstrated 




Kohanski et al.’s microarray data also showed the expression of ygiB to be up-
regulated when cells are treated with bactericidal drugs as opposed to bacteriostatic 
drugs. To check if deletion of ygiB and its homolog yjfM alters the sensitivity to 
bactericidal drugs we treated WT, ∆ygiBC (GD101), ∆yjfMC (GD103), ∆ygiBC-yjfMC 
(GD104), ∆speE (JW0117) and ∆gshB (JW 2914) strains with two different 
concentrations of norfloxacin, 250 ng/ml and 600 ng/ml. Norfloxacin is a bactericidal 
antibiotic and has been shown to generate damaging free radicals in E.coli cells 
(Kohanski et al., 2007).  All the strains were grown in LB medium until 0.3 OD600 and 
different concentrations of norfloxacin were added, aliquots of each culture were 
removed at 0 h, 1 h, 2 h and 3 h post addition of norfloxacin and plated onto LB-agar 
plates. A positive control without addition of antibiotic was also included. The graphs 
in figure III.14 represent colony forming units with respect to time of incubation after 
the addition of norfloxacin. As expected in the no drug control there was no difference 
observed in the number of viable cells between WT and ygiBC, yjfMC and ygiBC-
yjfMC deletion strains at any time point.  
                      When treated with 250 ng/ml norfloxacin all the strains showed a similar 
pattern of susceptibility. At 0 hour WT and all other mutants had the same number of 
viable cells ~10
10
 cells/ml (Figure III.14). The only small difference in the cell count 





 viable cells/ml, respectively.  ∆yjfMC, ∆ygiBC-yjfMC, ∆gshB 
and ∆speE strains had ~10
7
 viable cells/ml. This 10-fold difference may not be 
significant and could arise due to pipetting, dilution error or both. However different 




norfloxacin. ∆yjfMC strain was most susceptible as no colonies were observed just one 
hour post incubation with the antibiotic. After three hours incubation with antibiotic, 
WT had 10
8
 viable cells/ml, ∆ygiBC and ∆ygiBC-yjfMC strains had ~100-fold less 
number of viable cells than WT. ∆speE strain had ~10
6
 viable cells/ml and ∆gshB 
strain was completely susceptible to norfloxacin. Although, ∆ygiBC strains are more 
susceptible to 600 ng/ml norfloxacin than WT more experiments need to be done to 
conclude that ygiBC genes participate in protecting E.coli cells against oxidative stress.  
                      To investigate the possible role of ygiBC genes in protection against 
H2O2 we treated WT, ∆tolC strains, ∆ygiBC-yjfMC, ∆gshB, ∆speE and ∆gspS strains 
with different concentrations of H2O2 (Figure III.15). H2O2 is a potent oxidizing agent 
and damages cells membranes and DNA (Imlay & Linn, 1987). Overnight grown 
cultures were plated onto LB-agar plates. Filter paper discs with 20 µl either of 5%, 
15%, 30% H2O2 solution or water as a control was placed onto the plates. After 
overnight incubation at 37°C, a zone of clearing was scored.   The graphs represent 
average diameters of zone of clearing observed for each strain (Figure III.15). As 
expected the diameter of the clear zone increases with increasing concentrations of 
H2O2. However no significant difference in zone diameters was observed between WT 
and ∆tolC strains, ∆ygiBC-yjfMC, ∆gshB, ∆speE and ∆gspS strains indicating that 
glutathionylspermidine synthetase and glutathionylspermidine synthetase like enzymes 
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Figure III.14: Treatment with norfloxacin. Number of surviving cells (Log10 colony 
forming units (CFU) per milliliter culture) plotted against time after addition of drug.  
A: Cells treated with DMSO only. B: Cells treated with 250 ng/ml norfloxacin. C: Cells 




                    



















Figure III.15: Hydrogen peroxide disk diffusion assay. Cells exposed to 5% H2O2 
(A), 15% H2O2 (B) and 30% H2O2 (C)  
III.2.6 YgiBC are not required for GSH mediated protection against antibiotics. 
Previously it was shown that GSH when added to the extracellular medium protects 




2006). The mechanism of protection proposed is that GSH is a potent antioxidant and 
neutralizes the free radical species generated by bactericidal antibiotics (Goswami et al., 
2006 and Goswami et al., 2007).  To check if this protection by GSH is dependent on 
TolC, glutathionylspermidine synthetase or glutathionylspermidine synthetase like 
enzymes, we measured bactericidal activity of norfloxacin in the presence of GSH. For 
this purpose we treated WT, ∆tolC, ∆ygiBC-yjfMC, ∆tolC-ygiBC-yjfMC strains with 
increasing concentrations of norfloxacin, in the presence of 5 mM, 10 mM and 15 mM 
of GSH. Controls without GSH and with norfloxacin and vice versa were also set up. 
Consistent with previously published results, (Goswami et al., 2006) increasing 
concentrations of GSH protected WT cells from norfloxacin (Table 7, Figure III.16). In 
the presence of 15 mM GSH MICs of norfloxacin increased up to 32-fold. ∆ygiBC-
yjfMC strain showed similar level of resistance to norfloxacin as WT. Although notably 
less than WT, eight-fold protection in presence of 10 mM GSH was also seen in ∆tolC 
strains. ∆tolC-ygiBC-yjfMC strain showed four-fold increase in MIC of norfloxacin in 
presence of 5 mM GSH. From these results we can conclude that 
glutathionylspermidine synthetase like enzymes are not required for GSH mediated 
protection against norfloxacin.  
                       To check if TolC’s export function is required for GSH mediated 
protection against norfloxacin we subject ∆acrAB-acrEF strain, a strain lacking two 
major efflux transporters, to norfloxacin in presence of increasing concentrations of 
GSH. ∆acrAB-acrEF strain like WT also shows 32-fold increase in norfloxacin 
resistance in presence of 15 mM GSH. These results show that AcrAB/EF dependant 




                       Next, to check if this effect is also seen when cells are exposed to 
bacteriostatic drugs, we treated the above strains with different concentrations of 
erythromycin in presence of 5 mM, 10 mM and 15 mM GSH. Erythromycin is a 
macrolide antibiotic and is bacteriostatic in nature. WT cells showed up to 4-fold 
increase in resistance against erythromycin in presence of 15 mM GSH. ∆ygiBC-yjfMC 
and ∆acrAB-acrEF strains showed 8-fold increase in resistance to erythromycin. In 
contrast, both ∆tolC and ∆tolC-ygiBC-yjfMC strains were equally susceptible to 
erythromycin in the presence or absence of GSH. Taken together these results suggest 
TolC assists in the GSH mediated protection of cells against antibiotics and that GSH 
protection mechanism is not only restricted to its anti-oxidant property indicating that 
other mechanisms could also be involved in this process.  
 
III.2.7 Protection against antibiotics is specific to glutathione. We also investigated 
whether the same phenomenon of protection against antibiotics can be observed with 
spermidine. Therefore using the same strategy we measured MICs of erythromycin and 
novobiocin in the presence and absence of increasing concentrations of spermidine. 
Although novobiocin is bacteriostatic in nature, we chose it because like norfloxacin it 
inhibits DNA gyrase and thus inhibits DNA replication and cell division. MIC results 
show that unlike GSH, spermidine in concentrations up to 63.7 mM was well tolerated 
by ∆tolC-ygiBC strain (Table 8). No differences in MIC values of novobiocin were 
observed in the presence or absence of spermidine in both WT and ∆tolC-ygiBC strains. 
However, four-fold increase in MIC of erythromycin was observed for WT and ∆tolC-



















































as that observed for GSH mediated protection of erythromycin the effect was not as 
dramatic as seen for norfloxacin indicating that the protection against norfloxacin is 
specific to glutathione. Measurement of MIC of norfloxacin in the presence of 
spermidine should be done to confirm this result.  
 
 
A.                                                                       B. 
Figure III.16: TolC assists in GSH mediated protection against norfloxacin and 
erythromycin. A: Fold difference in MIC when cells are treated with norfloxacin. B: 











Table 7. MICs of norfloxacin and erythromycin in the presence of glutathione  
 
Table 8. Susceptibility of WT and ∆tolC-ygiBC strains to erythromycin (ERY) and 
spermidine (SPE). 
Minimum inhibitory concentration in µg/ml. ND-not detected, below limit. 

















BW25113 WT 0.04 0.16 0.64 1.28 128 512 512 512 
GD104 ∆ygiBC 
∆yjfMC 
0.04 0.16 0.64 1.28 64 256 256 512 
AG100AX ∆acrAB 
∆acrEF 
0.005 0.01 0.02 0.16 4 4 8 32 




0.005 0.02 - - 4 4 - - 
Minimum inhibitory concentration (MIC) WT GD102 
ERY 32 2 
 SPE >9250 >9250 
 ERY + 63.7 mM SPE 128 8 
Fold difference:(MIC (ERY+SPE)/MIC ERY only 4  4 
NOV 64 ND 
NOV + 63.7 mM SPE 64 ND 




III.3 Investigation of multifunctional interactions between TolC and 
transporters.  
III.3.1 Co-purification studies did not identify stable interactions between TolC 
and other proteins.  Our results show that TolC assists in GSH mediated protection 
against norfloxacin and erythromycin. In addition, we found that this protection is not 
dependent on AcrAB or AcrEF efflux pumps. Therefore, we hypothesized that other 
proteins participate with TolC in assisting in the GSH mediated protection against 
drugs. To identify these protein(s) interacting with TolC we constructed TolC cysteine 
mutants and expressed them from the chromosomal native promoter of tolC. The six 
histidine tag at the C terminus would aid in the easy one step purification of TolC. 
Cysteine replacements were created in positions Q352, D356, S363 and D374 (Figure 
III.17).  All of the residues are located in the periplasmic coiled coil domain of TolC, a 
region previously mapped as the interface of interaction with membrane fusion protein 
AcrA. Residues Q352, D356, S363 are located on helix 7 whereas residue D374 is 
located on helix 8 at the periplasmic entrance of TolC. These cysteine residues would 
help us to study TolC-MFP/protein interaction by in vivo cross linking, thiol labeling to 








     A.                                                                   B.                           















Figure III.17 Crystal structure of TolC with positions of cysteine substitutions 
shown as spheres. A. Side view of TolC and B. Periplasmic view of TolC with residues 
Q352-Red, D356-Blue, S363C-Pink and D374- Gold. Crystal structure from Koronakis 
et al., 2000.  
                                
                      To avoid non specific signals due to overexpression of TolC we created 






 were inserted at the TolC locus. These chromosomal insertion 
mutants were made using lambda red recombinase method (Datsenko & Wanner, 
2000). All the cysteine mutants along with TolC
his
 were expressed from the tolC native 
promoter. Colonies obtained after transformation and selection on LB + novobiocin 
plates were confirmed with PCR reaction using forward primer TolCstart and reverse 
primer TolChis (Appendix A). Next, membrane fractions were isolated to check 
expression of the TolC mutants. The expression profile shows that chromosomally 
expressed TolC cysteine mutants and TolC
his
 are expressed to a level lower than WT 
but show similar oligomeric patterns as WT TolC (Figure III.18). To ensure that these 
chromosomally expressed proteins are functional we measured drug susceptibility and 
colicinV secretion by these strains. All mutants with the exception of TolCS363C 
strain showed similar level of resistance (Table 9) and colicin secretion (Table 10) as 
WT. Surprisingly, TolCS363C strain showed 4-fold increased resistance to novobiocin 
and lincomycin. 
                       In order to determine if TolC forms a stable complex with any other 
protein(s), we purified TolCD356C protein using His-tag affinity chromatography. Due 
to chromosomal expression of TolC, we used sucrose density gradient centrifugation to 
separate both the inner membrane and outer membrane. Since TolC is an outer 
membrane protein, the outer membrane fraction was solubilized in detergent Triton X-
100 and then loaded onto Cu
2+
 charged His binding resin. TolC was eluted with 
increasing concentrations of imidazole. All fractions were separated on a 12% SDS-PA 
gel and visualized using silver staining. Purified TolC is detected as a band with a 




strain was also processed simultaneously as a control to identify proteins binding non-
specifically to the column. However, when compared to WT purification profile no 
unique TolC-specific proteins could be identified in purified TolC fractions (Figure 
III.19). 
                       Co-purification did not identify proteins that might interact with TolC, 
possibly because of transient nature of interaction between TolC and other proteins. 
Therefore, we next used cross-linking approach, previously reported by Lobedanz et.al 
(Lobedanz et al., 2007) to stabilize TolC-transporter complexes. In this approach, we 
used succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) cross linker. SPDP is a thiol 
amine crosslinker with a short spacer arm of 6.8 Å and would cross link the amine 
group of proteins with cysteine thiol group of TolCS363C. TolCS363C strain was 
incubated with SPDP and TolC-transporter complexes were affinity purified and 
analyzed on 12% SDS-PA gel. As a negative control, TolCS363C without cross linker 
was also processed in parallel (Figure III.20A). 
                      500 mM imidazole fractions of both cross-linked and non-crosslinked 
samples show several proteins co-purified along with TolCS363C. However, 
comparing the purification profiles of TolCS363C samples treated with cross-linker 
and samples without a cross-linker, SDS-PA gel could not detect proteins specifically 
co-purified with TolCS363C mutant. To confirm that cross linking was successful 
these fractions were transferred onto PVDF membranes. The membranes were probed 
with anti-AcrA, anti-AcrB and anti-TolC antibodies. Immunoblotting analysis showed 




(Figure III.20B). Immunoblotting analysis of non-crosslinked samples also shows 







 Figure III.18. Immunoblotting analysis of chromosomal TolC cysteine mutants. 
WT and ∆tolC-ygiBC strains were included as positive and negative controls 
respectively. 20 µg of total membrane proteins were separated on 12% SDS-PA gel. 
TolC is detected using polyclonal anti-TolC antibodies. + and – signs indicate boiled 
and un-boiled samples respectively. 
Table 9. MIC (µg/ml) of TolC cysteine mutants expressed from chromosome.   
SDS: Sodium dodecyl sulfate, Nov: Novobiocin, Lin: Lincomycin, Ery: Erythromycin 
 
 











Ery 32 1 32 32 32 32 32 
Lin 312.5 39 312.5 312.5 1250 312.5 312.5 
Nov 64 1 64 64 256 64 64 




Table 10. Colicin V secretion assay. Chromosomally expressed TolC cysteine mutant  












                             A                                         B 
Figure III.19  Purification profiles of WT (A) and TolCD356C (B) strains. All 
fractions were boiled in SDS-loading buffer, separated by 12% SDS-PA gel and 

























                               
                        
 







Figure III.20 Purification of TolC S363C after treatment with SPDP cross linker.  
A. Purification profile of TolCS363C mutant in the presence (+SPDP) and absence 
 (–SPDP) of cross linker. All fractions were resolved on 12% SDS-PA gel and proteins 
were visualized by silver staining. B. Western blotting analysis of 500 mM imidazole 
fractions. + SPDP, - SPDP, c- purified TolC, AcrB and AcrA included as positive 




 III.3.2 Accessibility of TolC cysteine residues unaltered in the presence of 
additional transporters. In agreement with previous studies our cross linking results 
show that AcrA is in close association with TolCS363C. We hypothesized, that since 
this residue is involved in stable protein-protein interaction with AcrA it would not be 
accessible to a thiol reactive dye. To check the accessibility of this residue and other 
cysteine residues we used a thiol-reactive fluorophore, fluorescein 5 maleimide (F5M). 
The maleimide moiety of F5M reacts with thiol group of cysteine residue to form a 
stable thioether bond. Cells were incubated with 0.25 mM F5M for 30 min. The 
reaction was stopped with 1 mM DTT (see experimental procedures). Membrane 
fractions from each strain were isolated. WT and GD102 strains were included as 
positive and negative controls respectively. Membrane proteins were separated on a 
12% SDS-PA gel. The gel was first scanned for fluorescence signal using Storm 
scanner and then stained with Coomassie Brilliant Blue to visualize proteins (Figure III. 
21 top panel). To confirm equal levels of expression, immunoblotting using anti-TolC 
antibodies was also done with the same fractions (Figure III.21 bottom panel).  
                       As expected, WT TolC and cysteineless TolC
his
 showed no fluorescence 
signal. TolC Q352C residue was also not labeled with F5M, indicating that either this 
residue is blocked by AcrA/ other protein(s) interacting with it or its physical 
orientation prevents its accessibility to F5M. Residue D374C at the periplasmic 
entrance did get labeled with F5M. Surprisingly, TolC S363C residue was also labeled 
with F5M indicating that this residue is not blocked by AcrA but freely available for 
labeling. This can be explained by two possibilities. First, TolC transiently interacts 




time some molecules of TolC may be available for labeling whereas some TolC 
molecules may be blocked by the AcrAB proteins. Second, TolC may exist as a 
heterogeneous population, some TolC molecules are involved in stable association with 








Figure III.21. In vivo labeling with F5M.  Whole cells were labeled with F5M.  
Membrane fractions were isolated and 20 µg total membrane proteins were separated 
with 12% SDS-PA gel. The gel was first scanned for fluorescence and then the proteins 
were transferred onto PVDF membrane. The membrane was then probed with 
polyclonal anti-TolC antibody. 
 
                      To test the above mentioned possibilities, TolC D356C, S363C and 
TolC
his
 strains were transformed with plasmids expressing colicin V (pBR322 with 
cvaABC and cvi genes, pHK11) (Hwang et al., 1997) and MacAB (pBAD with macAB, 
pBADMacAB (Tikhonova et al., 2007). Colicin V is a 9 kDa antibacterial protein 




Enterobacteriaceae family. Colicin V is secreted by CvaABC type I system. In this 
complex, CvaB is an inner membrane ABC type transporter, with the ATP binding 
domain in the C-terminal cytoplasmic domain. CvaA belongs to the membrane fusion 
family of proteins and helps in the secretion of colicin V. It has been shown previously 
that CvaAB recruits TolC only in the presence of its substrate, colicinV (Hwang et al., 
1997). MacAB is an ABC type macrolide efflux transporter and confers resistance to 
macrolides composed of 14 and 15 membered lactones. It was shown recently that 
MacAB is also involved in the secretion of heat stable enterotoxin II in E. coli 
(Yamanaka et al., 2008). Previous studies have shown that MacAB also requires TolC 
for its export function and that MacA can bind to TolC in vivo. We hypothesized that if 
indeed TolC exists as a heterogeneous population, then in the presence of an additional 
transporter the labeling of TolC cysteine residues will change.  
                      For this purpose TolC D356C, S363C and D374C and TolC
his
 
transformed with either pHK11 plasmid or pBADMacAB plasmid were labeled with 
F5M. As controls the same strains without plasmids were also labeled with F5M. An 
aliquot of the cells was used to confirm active colicin V secretion (described in 
experimental procedures). MacAB expression was induced with 0.2% arabinose for 3 
hr. Membrane fractions were isolated from all strains and the proteins were separated 
on 12% SDS-PA gel, scanned for fluorescence labeling and then stained with 
coomassie blue stain (Figure III.22). As expected cysteineless TolC
his
 was not labeled 
with F5M, whereas D356C, S363C and D374C residues were accessible to F5M even 
in the presence of CvaAB. In case of MacAB, the signal resolution was poor due to 




results. However, fluorescence scanning results show that cysteine accessibility pattern 
was unaltered even in the presence of CvaAB transporter. In this experiment we could 
not distinguish between the two explanations that TolC exists as a heterogeneous 
population or that AcrAB-TolC interactions are transient in nature. Also, from the 
results of these experiments we cannot rule out the possibility that different MFP-
transporter complexes contact different surfaces on TolC and that residues D356C, 
S363C and D374C may not lie at interaction sites. Further experiments are needed to 
understand how TolC is engaged into complexes. 
                      Next we constructed TolC cysteine mutants that lack AcrAB (Appendix 
A). These mutants will be used to check the cysteine accessibility pattern in the 
absence of AcrAB. AcrAB deletions in TolC cysteine strains were created using 
lambda red recombination. The deletion mutants were confirmed with PCR using 
primers specific to kanamycin gene and the region downstream of AcrB. Deletion of 
AcrA was also confirmed by western blotting analysis using anti-AcrA antibodies. 



















Figure III.22. Cysteine accessibility to F5M in the presence CvaAB and MacAB. 
Cells transformed with different plasmids were labeled with F5M in vivo. Membrane 
fractions were isolated and membrane proteins were separated with 12% SDS-PA gel. 
The gel was first scanned for fluorescence and then stained with coomassie blue stain. 
 
III.3.3 Real time labeling of TolC cysteine residues. Previous studies with hemolysin 
transporter, HlyBD suggested that TolC may be recruited only in the presence of 
substrates (Koronakis et al., 1995). Therefore we hypothesized that increasing 
concentrations of drug (substrate) would protect the cysteine residues from the thiol 
reactive probe and thus the rate of labeling of TolC cysteine residues would decrease 
proportionally. This competition between drug and probe would in turn help us 
determine the rate of efflux of substrates through the TolC channel. Rate of labeling of 
cysteine residues is a function of concentration of fluorophore, rate of entry of 




fluorophore and rate of entry of fluorophore into the cell being constant for all strains, 
the rate of labeling will be solely determined by the position/accessibility of the 
cysteine residues. As all the cysteine residues are located in the periplasmic region of 
TolC, we were interested in determining the rate at which these residues get labeled 
and if the rate of labeling is altered in the presence of drugs.  
                    For this purpose we used a thiol specific fluorescent dye, 7-diethylamino-
3-(4'-maleimidylphenyl)-4-methylcoumarin (CPM). CPM is membrane permeable and 
like F5M, CPM is not fluorescent until after conjugation with a thiol group. This 
conjugate has an excitation and emission wavelength of 384 and 470 nm respectively. 
Two strains, WT cysteineless TolC as a negative control and TolCD374C strain were 
used to determine the optimum CPM concentration and specificity of labeling. In order 
to optimize CPM concentration for labeling we kept cell density constant at 0.2 OD600 
and used five different concentrations of CPM (1-5 µM).  
                    As expected TolCD374C showed higher rate of labeling than WT 
cysteineless TolC. Also, the rate of fluorescence increased with increasing 
concentrations of CPM and remained constant at concentrations of 2 µM and higher 
(Figure III.23A).  
                     Next we wanted to check how the rate of labeling increases with 
increasing number of cells. For this purpose we used two concentrations of CPM, 1 
µM and 5 µM and increased the number of cells from 0.05 OD600 to 0.6 OD600. As 
expected, the rate of fluorescence labeling increased proportionally with increasing 
number of cells (Figure III.23 B, C). Our results indicate that the rate of increase in 




                      To check if different cysteine residues have different labeling rates, we 
used TolCQ352C, D356C, S363C, D374C and TolC
his
 strains. WT and GD102 were 
included as positive and negative controls respectively (Figure III.24). All strains 
showed similar rates of labeling except for TolCD374C strain (Table 11). TolCD374C 
strain showed slightly higher rate of labeling than WT or other TolC cysteine residues. 
This result indicates that residue 374C is more accessible to the fluorophore than other 
cysteine residues.                                                    
                      As this difference in labeling rates was small as compared to WT, we 
checked the labeling of TolCD374C and TolC
his
 expressed from plasmids. For this, we 
transformed GD102 (∆tolC-ygiBC) strain with plasmids expressing TolCD374C 




). Four strains, the chromosomally 
expressed TolCD374C and TolC
his
 and GD102/pTolCD374C and GD102/ pTolC
his
 





 expressed from plasmid showed similar rates of labeling. The rate of 
labeling increased proportionally between 1 µM and 5 µM CPM and then remained 
constant at higher concentrations of CPM (Figure III. 25A). Chromosomally expressed 





the rate of labeling of chromosomally expressed TolCD374C increased proportionally 
with increasing concentrations of CPM. As expected GD102/pTolCD374C strain 
showed the highest rate of labeling. Rate of labeling increased proportionally up to 10 






















Figure III.23. In vivo labeling with fluorophore, CPM A. Rate of increase in labeling 
with increasing concentrations of CPM, cell density kept constant. B. Rate of labeling 















Figure III.24.  Whole cell labeling with fluorophore, CPM. WT and GD102 strains 
were used as positive and negative controls. The rate of labeling is determined as the 
slope of the individual graphs. 
 









               




TolC Q352C 0.26 
TolC D365C 0.25 
TolC S363C 0.27 







                        To check the effect of substrates on rate of labeling of TolC, we used 
GD102/pTolCD374C, GD102/pTolC
his
 strains. TolCD374C was chosen because it is 
located at periplasmic entrance aperture of TolC and is said to contact substrates. 
Puromycin was selected as substrate as puromycin’s absorption spectrum does not 
interfere with the excitation and emission wavelengths of CPM and is an excellent 
substrate for the AcrAB-TolC multidrug efflux pump. The structure of puromycin is 
analogous to aminoacyl t-RNA. Puromycin binds to the ribosome releasing the nascent 




































Figure III.25. Real time labeling of TolCD374C and TolC
his
 with CPM. A. Rate of 
labeling of TolCD374C and TolC
his
 expressed from plasmid. B. Rate of labeling of 
TolC D374C and TolC
his






                      GD102/pTolCD374C, GD102/pTolC
his
 strains were labeled in the 
presence of 5, 10, 15 and 20 µM puromycin (Fig III. 25B).   Increasing concentrations 
of puromycin did not alter the rate of labeling of TolCD374C.  To check if induction of 
expression of TolCD374C would have an effect on the labeling rate we induced 
pTolCD374C and pTolC
his
 with 0.1 mM IPTG at 0.3 OD600. The cells were harvested at 
0.6 OD600 and then labeled with CPM in the presence of increasing concentrations of 
puromycin. The rates of labeling were unaltered in the presence of increasing 
concentrations of puromycin. Induction of TolCD374C expression also did not affect 
the rate of labeling of pTolCD374C residue in the presence of increasing concentrations 
of puromycin. Unexpectedly in the presence of IPTG, pTolCD374 showed lower rate of 
labeling than in the absence of IPTG indicating that IPTG could inhibit the labeling 













IV.1 ∆TolC strains are unable to efficiently metabolize glucose. 
                    Through the course of these studies we found that ∆TolC strains have 
severe defects when growing in M9 medium. These growth defects manifest as reduced 
growth rates, extended lag phase and altered cell morphology (Figures III.8A and 
III.8B). Furthermore loss of YgiB, YgiC and their homologues further exacerbates this 
∆TolC phenotype.  
                    Growth defects in ∆tolC, ∆tolC-ygiBC and ∆tolC-∆ygiBC-∆yjfMC strains 
were only observed when these strains were grown in M9 medium with glucose as 
carbon source. In LB medium these strains showed the WT phenotype. LB medium is a 
rich source of vitamins, pyruvate and intermediates of amino acids and nucleotide 
biosynthetic pathways. Cells utilize these intermediates along with pyruvate to derive 
energy through gluconeogenesis (Isenberg & Newman, 1974). However, M9 medium is 
a chemically defined medium and cells must use M9 salts as a source of phosphates, 
ammonium, and sulfates. Glucose is supplied as carbon source and cells generate 
energy through glycolysis. The difference in growth phenotypes of these strains in LB 
and M9 medium strongly indicated that ∆tolC strains experience a metabolic deficiency. 
Indeed growth defects in ∆tolC strains can be completely compensated by the addition 
of amino acid L-serine to the growth medium (Figure III.6)  
                     E.coli K12 strain cannot utilize L-serine as a carbon source but L-serine 




serine is required for the synthesis of phosphatidylserine, a minor phospholipid in the 
E.coli cytoplasmic membrane. However phosphatidylserine serves as the key 
intermediate for synthesis of phophatidylethanolamine the major lipid in the E.coli 
bilayer (Raetz, 1976) making it important for lipid biosynthesis. L-serine also serves as 
a precursor for the synthesis of L-glycine and L-cysteine. However neither glycine nor 
cysteine could restore the growth phenotype in ∆tolC strains indicating that growth 
defects observed were not due to deficiency of either of the amino acids. E.coli enzyme 
L-serine deaminase converts L-serine to pyruvate (Isenberg & Newman, 1974), an 
intermediate of the glycolysis/gluconeogenesis pathway. Therefore cells can utilize 
pyruvate and generate energy through glycolysis. In E.coli, L-alanine, L-cysteine and L-
tryptophan are the only amino acids that can be converted to pyruvate 
(http://ecocyc.org) all other amino acids such as aspartate and glutamate are degraded to 
intermediates of the TCA cycle. Although we did see a small increase in the growth 
rates of ∆tolC-∆ygiBC-∆yjfMC strain in the presence of glutamate and aspartate the lag 
phase still persisted. Also, keeping the LB growth phenotypes in perspective, led us to 
the preliminary conclusion that the glycolysis pathway was inhibited in ∆tolC strains. 
                       Phosphoenolpyruvate phosphotransferase system is the major pathway 
for transport of sugars in E.coli. Glucose, fructose, mannitol and sorbitol are PTS-
dependent sugars whereas glycerol, xylose, maltose and lactose are non-PTS sugars 
(Meadow et al., 1990). Therefore, E.coli encodes specific transporters for these non-
PTS sugars. Results of our experiments with different carbon sources indicate that the 
metabolism of glucose is affected but not its transport in ∆TolC strains. Glucose is 




dependent phosphotransferase system (PTS), PtsG and also has been demonstrated to be 
transported in a PTS dependent manner by mannose transporter ManZ (Meadow et al., 
1990 and García-Alles et al., 2002). Glucose is immediately phosphorylated to yield 
glucose-6-phosphate, an intermediate of glycolysis. Similar to glucose, fructose is also 
transported by the PTS ManZ system and is phosphorylated to fructose-6-phosphate 
(Kornberg, 2001). However, fructose is also taken up by the fructose specific membrane 
spanning transporter FruA and is phosphorylated to fructose-1-phosphate. The fructose-
1-phosphate formed is further phosphorylated by ATP and 1-phosphofructokinase 
(FruK) to fructose 1, 6-bis phosphate (Kornberg, 2001). As ∆TolC strains are able to 
utilize fructose, glycerol and xylose we believe that the bottleneck for the ∆TolC strains 
to utilize glucose is in the early stages of glycolysis. Our experiments indicate that the 
conversion of glucose-6-phosphate to fructose-6-phosphate and fructose-6-phosphate to 
fructose-1, 6-bis phosphate catalyzed by enzymes phosphoglucose isomerase and 
phosphofructokinase respectively may be affected.  
                      Phosphoglucose isomerase encoded by the pgi gene participates in both 
glycolysis and gluconeogenesis. Previous studies have shown that pgi belongs to the 
SoxSR transcriptome (Pomposiello et al., 2001 and Blanchard, 2007). Furthermore, 
Rungrassamee et.al show that both PtsG and Pgi are required for survival for E.coli 
during oxidative stress  (Rungrassamee et al., 2008) . Their data also shows that 
oxidative stress conditions induce the expression of both PtsG and Pgi. They further 
discuss that during oxidative stress Pgi redirects the  carbon metabolism through the 
pentose phosphate pathway producing NADPH as reducing equivalents. The pentose 




phosphate is further converted to two molecules of fructose-6-phosphate and a molecule 
of glyceraldehyde-3-phosphate. The resulting fructose-6-phosphate and glyceraldehyde-
3-phosphate can either be catabolized through glycolysis, or recycled via 
gluconeogenesis. Although not the most efficient pathway for producing energy but one 
molecule of glucose-6-phosphate through six cycles of pentose phosphate pathway and 
gluconeogenesis can produce 6 CO2 and 12 NADPH (Rungrassamee et al., 2008).  
                        TolC like Pgi and PtsG belongs to the SoxS transcriptome and is 
required for survival E.coli under oxidative stress conditions (Rosner & Martin, 2009). 
Also, strong evidence suggests that normal glucose metabolism is affected when cells 
experience oxidative stress (Rungrassamee et al., 2008). Taken together these findings 
and our results that ∆TolC strains are not able utilize glucose suggest that deletion of 
TolC induces oxidative stress like conditions in E.coli cells. This in turn leads to 
inefficient glucose metabolism as explained by slow growth rates and therefore does not 
affect their ability to survive.   
IV.2 Inactivation of TolC leads to depletion of NAD
+
. 
 To further investigate the reason for poor growth on glucose minimal medium we 
measured the NADH and NAD
+
 concentrations in WT and ∆tolC strains. Significant 
differences were observed in NADH/NAD
+
 ratios between WT and ∆tolC strains (Table 
3a). In M9 medium stationary phase ∆tolC strain showed three-fold lower [NAD
+
] than 
WT whereas ∆tolC-ygiBC-yjfMC strain had 14-fold lower concentration of NAD
+
 






                        NADH/NAD
+
 ratios are tightly regulated in the cell as high 
NADH/NAD
+
 ratios inhibit key enzymes of the TCA cycle such as citrate synthase and 
malate dehydrogenase (Prüss et al., 1994). TCA cycle is a part of the metabolic 
pathway that is used to generate energy in the cell. In addition, TCA cycle also provides 
precursors for amino acid and nucleotide biosynthesis.  High NADH/NAD
+
  ratio has 
also been shown to inhibit pyruvate dehydrogenase complex of E.coli (Kim et al., 
2008). Pyruvate dehydrogenase complex connects glycolysis with TCA cycle and 
catalyses the conversion of pyruvate to acetyl CoA with the reduction of NAD
+
 to 
NADH. Therefore abnormal NADH/NAD
+
 ratios lead to inhibition of key metabolic 
enzymes which in turn leads to metabolic shut down.  
                      Despite the dramatic drop in NAD
+
 levels, NADH levels in ∆tolC strains 
still remained high (Table 3a). This indicates strongly that oxidation of NADH was 
inhibited. We found that rates of NADH oxidation in GD105 membranes decreased 
significantly upon entry into stationary phase and remained only at 50% level of the WT 
(Table 4). E.coli has two membrane bound NADH dehydrogenases, NDH-I and NDH-II 
(Pruss et al., 1994). NDH-I couples NADH oxidation to produce PMF. Previous studies 
showed that mutational inactivation of NDH-I leads to growth defects during transition 
into the stationary phase (Pruss et al., 1994).  These growth defects could be suppressed 
by serine. Similarly presence of L-serine in M9 medium suppressed growth defects 
observed in ΔtolC cells. Taken together these findings suggest that TolC inactivation 
leads to inhibition of NDH-I, which in turn results in metabolic shutdown and 




                      NADH acts as an iron reductant in a Fenton reaction and drives DNA 
damage by iron and peroxide in vivo (Brumaghim et al., 2003). Previous studies showed 
that raising the NADH level in vivo by eliminating or negatively regulating NADH 
dehydrogenase activity dramatically sensitizes E. coli to killing by peroxide (Imlay & 
Linn, 1988). Also, recently it was reported that cells lacking TolC overproduce SoxRS, 
Rob and MarA stress response factors (Rosner & Martin, 2009). SoxRS system is 
activated by exposure to superoxide and nitric oxide, MarA is activated by exposure to 
antibiotics and phenols and Rob, when cells are exposed to 2, 2-dipyridyl or bile salts 
(Rosner & Martin, 2009). Thus, high levels of NADH in GD105 cells could contribute 
significantly to oxidative stress in these cells. We suggest that inhibition of NDH-I and 
rising levels of NADH are the major reasons for the induction of SoxS, MarA and Rob 
stress responses in the cells lacking TolC. Therefore we believe that the poor growth of 
∆tolC strains on M9 minimal medium is due to metabolic shut down and oxidative 
stress caused in the stationary phase. 
IV.3 Inactivation of TolC leads to depletion of intracellular glutathione.  
                        The growth defects in ∆tolC strains are exacerbated in the absence of 
YgiB, YgiC and their homologues, YjfMC. As YgiC and YjfC are predicted to be an 
enzyme glutathionylspermidine synthetase we further wanted to investigate if the 
defects in growth were due to lack of glutathionylspermidine. Therefore we measured 
the intracellular concentration of GSH in these strains. As ∆tolC strains had prolonged 
lag phase after inoculation into fresh medium, we collected samples during LB to M9 




analysis shows that in LB medium ∆tolC strains had WT levels of GSH. However, a 
significant drop in GSH level was seen after incubation for one hour in M9 medium. 
Levels of GSH further decreased as incubation time in M9 medium increased. The 
possible reasons for this dramatic drop in total GSH concentration could either be due to 
oxidation of GSH to GSSG by enzyme glutathione oxidoreductase or halt in GSH 
biosynthesis and degradation of GSH into its individual amino acids.                           
                        Glutathione reductase assay was used to measure the total intracellular 
glutathione (both oxidized and reduced) concentration. Consistent with results of HPLC 
experiments results of glutathione reductase assay confirmed that ∆tolCygiBCyjfMC 
strain had reduced levels of total glutathione when transferred to M9 medium. These 
results strongly indicate that the reduction in GSH levels was not due to oxidation of 
GSH to GSSG. The decrease in GSH levels in ∆tolC strains could be explained by halt 
in GSH biosynthesis and degradation of GSH into its individual amino acids. We 
believe that abnormal NADH/NAD
+
 ratios in ∆tolC strains cause metabolic shut down 
in ∆tolC strains which results in halt in amino acid, nucleotide and GSH biosynthesis.  
A halt in amino acid biosynthesis requires degradation of the abundant intracellular 
GSH into γ-glutamyl and cysteinyl glycine residues. Previous studies have 
demonstrated that E.coli can use both these residues as an amino acid source (Suzuki et 
al., 1993).  GSH degradation is catalyzed by enzyme γ –glutamyltranspeptidase. 
Interestingly in E.coli this enzyme is localized in the periplasmic space (Suzuki et al., 
1993). Therefore for degradation of GSH, cytosolic GSH has to be transported to the 
periplasm and the degradation products need to be transported back into the cytoplasm. 




                       Glutathione reductase assay was also used to assay the GSH exported out 
from the cells. Surprisingly extracellular medium of M9 12 hour ∆tolC and 
∆tolCygiBCyjfMC strains show ~8-fold and ~9-fold more GSH in extracellular medium 
than WT. From these results we can conclude that TolC is not required for export of 
GSH. We believe that the major reasons for depletion of GSH in ∆tolC strains could be 
halt in GSH biosynthesis, degradation of GSH and export of GSH. However the 
mechanism and reasons for trigger of GSH export in ∆tolC strains remains to be 
studied. 
IV.4 Deletion of TolC induces stress on E.coli membranes.  
Protein expression profiles of stationary phase ∆TolC cells show the presence of large 
amounts of protein PspA. PspA is a 25 kDa cytoplasmic protein, also found to be 
associated with the inner membrane.  PspA is expressed in pspABCDE operon. In 
E.coli, psp operon is transcribed by σ
54
-RNA polymerase and also requires activation by 
PspF (Hankamer et al., 2004). PspF is a DNA binding transcriptional activator of the 
psp operon (Darwin, 2005) and is divergently transcribed from the pspABCDE operon. 
Brissette et.al in 1990 first reported that PspA was induced during filamentous phage 
infection (Brissette et al., 1990).  psp operon is also strongly induced by exposure to 
adverse conditions such as heat shock, osmotic shock, treatment with ethanol and 
proton ionophores such as carbonylcyanide-m-chlorophenylhydrazone (CCCP) (Weiner 
& Model, 1994). Mislocalization of membrane proteins and the inhibition of protein 
secretion by blockage of the Sec secretion machinery have also been shown to induce 




conditions is that they lead to dissipation of the PMF (proton motive force). Kobayashi 
et al. demonstrated that PspA helps modulate this stress by binding to the inner 
membrane of E.coli and forming large oligomers which prevent proton leakage from 
damaged membranes (Kobayashi et al., 2007).  PspA is also known to bind to 
transcription factor PspF thereby negatively regulating its own expression. The model 
proposed for PspA induction is such that under normal conditions PspA binds to PspF 
and prevents activation of the psp operon. Under membrane stress proton motive 
dissipating conditions PspA binds to membrane and forms large oligomers thus freeing 
PspF. Free PspF in turn activates expression of the psp operon. Thus inner membrane 
localization and overproduction of PspA is a strong indication of membrane stress and 
proton motive force dissipating conditions.  
                        Membrane fractions of stationary phase ∆TolC strains grown in M9 
medium show the presence of PspA indicating that ∆TolC strains experience membrane 
stress in stationary phase. It has been demonstrated that the major stress experienced by 
cells during stationary phase is oxidative stress (Nystrom, 2004). Protein and lipid 
oxidation leads to production of reactive oxygen species (ROS) generated by the 
electron transport chain that can in turn damage DNA and membranes (Nystrom, 2004). 
As cells lacking TolC overproduce SoxRS, Rob and MarA stress response factors 
(Rosner & Martin, 2009) we believe that the TolC channel is required for the export of 
toxic metabolites, ROS generated due to oxidative stress in the stationary phase. In the 
absence of TolC these toxic metabolites accumulate in the periplasm, cause oxidation of 
membrane protein and lipids thus creating stress on the membrane. Our results of 




glycerol, fructose and L-serine could complement the slow growth defects of ∆TolC 
strains, membrane fractions of ∆TolC strains grown in M9 medium either supplemented 
with glycerol or L-serine still showed the presence of PspA. These results strongly 
indicate that TolC is required to combat the oxidative stress experienced in the 
stationary phase.  
                       Results of determination of colony forming units and LIVE/DEAD cell 
viability assay kit confirm that although ∆tolC strains experience membrane stress in 
stationary phase the viability of these cells is not affected. From this result we can 
conclude that the lag phase experienced by these strains is not due to lower number of 
viable cells in the stationary phase but due to the time required to replenish essential 
metabolites and repair membranes.  
                        In summary, we propose the following model for the role of TolC and 
YgiBC in E.coli metabolism and physiology (Figure IV.1). Deletion of TolC inhibits 
NADH oxidases like Ndh-I. This in turn leads to increased concentrations of NADH 
and therefore an abnormal NADH/NAD
+
 ratio which ultimately results in metabolic 
shutdown. Inhibition of NADH oxidases and accumulation of NADH induces the 
formation of reactive oxygen species (ROS) which in turn activates the expression of 
Mar, Sox, Rob regulon. Transcriptional activator SoxS induces the expression of 
phosphoglucose isomerase which redirects the carbon metabolism through the pentose 
phosphate pathway as evidenced by slow growth. Lastly, we believe that inhibition of 
NADH oxidases in ∆TolC strains probably occurs due to stress on E.coli membranes 




membrane integrity. This stress on membranes is probably generated due to the 
accumulation of toxic metabolites as they are unable to exit the cells. 
 








IV. 5 TolC mediated GSH protection against antibiotics. 
As TolC is a key player in conferring antibiotic resistance we wanted to check if 
spermidine or glutathione affect drug susceptibilities in ∆tolC and ∆ygiBC-∆yjfMC 
strains. Spermidine did not alter the drug susceptibility in WT and ∆tolC-ygiBC strains. 
Previous studies showed that GSH protects E.coli cells against harmful effects of 
norfloxacin (Goswami et al., 2006). In accord with these results our results also show 
up to 32-fold increased resistance for norfloxacin. Norfloxacin is bactericidal drug and 
has been shown to generate free radicals thus causing oxidative stress inside cells 
(Kohanski et al., 2007). Therefore, the proposed mechanism for this GSH mediated 
protection was that GSH acts as an anti-oxidant and scavenges the free radicals 
produced by norfloxacin. However our results as well as Goswami et.al’s results show 
up to 8-fold increase in resistance against erythromycin in the presence of 15 mM GSH 
in WT and ∆ygiBC-∆yjfMC strains (Goswami et al., 2007). Unlike norfloxacin, 
erythromycin is a bacteriostatic drug and does not induce free radical formation in 
E.coli cells (Kohanski et al., 2007). The observation that GSH mediated protection 
against norfloxacin is 6-fold higher than that observed for erythromycin in WT cells, 
suggests that the GSH antioxidant property may in part protect cells against the effects 
of norfloxacin. However this protection mechanism is not restricted only to the 
antioxidant property of GSH. 
                        Our results indicate that GSH mediated protection against antibiotics 
requires presence of functional TolC channel. In case of erythromycin, no protection by 
GSH was observed in the absence of TolC indicating importance of TolC in protection 




to 4-8-fold protection was observed in presence of 10 mM GSH as compared to 16-32-
fold in WT. As TolC is known to function with major efflux pumps such as AcrAB and 
AcrEF we next wanted to determine if AcrAB or AcrEF are involved in this GSH 
mediated protection against antibiotics. Like WT, ∆acrAB-acrEF strain also showed 
upto 32-fold protection against norfloxacin and 8-fold protection against erythroycin in 
presence of 15 mM GSH indicating that GSH mediated protection of antibiotics does 
not require functional AcrAB and AcrEF efflux pumps. Thus, in summary our results 
strongly indicate that mechanism of GSH mediated protection requires both a functional 
TolC channel as well as the anti-oxidant property of GSH. The exact mechanism of 
GSH mediated antibiotic protection is not known and requires further studies. 
                        In eukaryotic cells glutathione conjugates of xenobiotics are exported out 
of the cell by specific transporters. This glutathione conjugation reaction is catalyzed by 
glutathione-S-transferases (Vuilleumier, 1997). E.coli does not possess such 
transferases; however the periplasmic enzyme glutathione transpeptidase has been 
shown to degrade GSH and transfer the γ-glutamyl group to amino acids and peptides 
(Suzuki et al., 1993). Also, previous studies have demonstrated export of glutathione 
conjugates in E.coli cells (Kałuzna & Bartosz, 1997). Therefore we propose that γ-
glutamyl or glutahtione conjugates of antibiotics are transported from the periplasm 







IV.6 Dynamics of TolC-MFP interactions.  
Functional TolC channel is required for GSH mediated protection against antibiotics. 
Therefore, we hypothesized that other proteins participate with TolC to aid in its 
function. For this purpose we constructed four TolC cysteine replacement mutants with 
cysteine replacements at residues Q352, D356, S363 and D374, as these residues have 
been demonstrated to lie at the TolC-AcrA interaction interface (Lobedanz et al., 2007). 
Each of these mutant TolC proteins also had a six histidine tag at its C-terminal. A 
cysteineless TolC with six histidine tag at its C-terminal, TolC
his
 was also constructed 
and served as a control. We were able to successfully express these proteins from the 
native TolC promoter from the E.coli chromosome. Functional analysis confirms that 
these mutants are functional. 
                       Co-purification studies using TolCD356C mutant did not identify any 
specific proteins forming a stable complex with TolC indicating that TolC may form 
transient complexes with proteins interacting with it. To confirm this, we employed the 
cross-linking strategy used previously (Lobedanz et al., 2007) and subject TolCS363C
his 
strain to a thiol amine cross-linker, SPDP. In accord to previously published results we 
were able to detect AcrA in crosslinked samples as well as small amount of AcrA could 
also be detected in non-crosslinked samples indicating that AcrA is in close association 
with TolC. This difference in the amount of AcrA crosslinked and co-purified without a 
cross-linker suggests strongly that TolC-AcrA complexes are transient in nature. Indeed 
we observed that although AcrA is in close association with TolC all the cysteine 
residues except for residue 352C were accessible to F5M confirming the transient 




                         The results of these in vivo experiments are in agreement with the 
recently published in vitro experiments characterizing the MFP-TolC interactions 
(Tikhonova et al., 2009). Tikhonova et al.’s results demonstrate that TolC-MFP 
interactions are highly dynamic in nature and the lifetime of these complexes range 
from seconds to minutes. Their data also shows that different MFP’s bind to TolC with 
different affinities. Of the tested MFP’s MacA of the MacAB macrolide efflux system 
has been shown to have maximum affinity followed EmrA and then AcrA. 
                        Although our in vivo results correlate with the recently published in vitro 
results we cannot refute the possibility that TolC can exist as a heterogeneous 
population. We used two approaches to test this possibility. First, we systematically 
deleted AcrAB from chromosome of TolC cysteine mutant expressing E.coli strains. 
F5M labeling of these strains will give us a better understanding about the dynamics of 
TolC-MFP interactions. Second, we transformed these TolC cysteine expressing E.coli 
strains with plasmid expressing colicinV and its transporter, CvaAB. However as the 
F5M labeling pattern was unaffected in the presence of an additional transporter we 
were not able to distinguish between the two possibilities. Further experiments are 
required to understand how TolC is engaged into complexes.  
                        Previous studies with HlyBD and CvaAB transporters have demonstrated 
that TolC is recruited by these transporters only in the presence of substrates therefore 
we hypothesized that increasing concentrations of drugs would protect the cysteine 
residues and the hence decrease the rate of labeling of these residues with a fluorophore. 




cysteine mutant strains had similar rates of labeling except for TolCD374C strain.  TolC 
D374C strain showed approximately two-fold increase in the rate of labeling. This 
increase in rate of labeling can be attributed to the position of the residue. Residues 
D371 and D374 are shown to line the periplasmic constriction of the TolC channel 
(Andersen et al., 2002). Andersen et al. show that mutation of D371 and D374 residues 
to alanine residues slightly enlarges the TolC channel. Therefore we believe that 
mutation of D374 residue to cysteine residue can moderately enlarge the TolC 
constriction which results in a leaky TolC channel thereby increasing the rate of 
labeling of the cysteine residue. 
                       We attempted to determine rate of efflux of substrate through the TolC 
channel. For this we used TolCD374C and TolC
his
 strains to detect competition between 
fluorophore and puromycin. We expected to see a decrease in labeling rate of the 
cysteine residue in the presence of increasing concentrations of drug, puromycin. 
However in our experiments increasing concentration of puromycin did not affect the 
rate of labeling of TolC D374C residue. Several reasons can account for this 
observation. First, as the life time of AcrA-TolC complexes is only a few seconds the 
drug efflux step probably takes place within seconds. Such a fast reaction would be 
difficult to monitor with this system. Some other technique such as stop-flow can be 
used to monitor the efflux of drug. Second, the ratio between fluorophore and drug may 
not have been optimal. Therefore further optimization with different concentrations of 
fluorophore and different drug needs to done. Although we were not able to determine 
the rate of efflux of drugs, these chromosomal TolC cysteine mutant strains provide a 
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- - - - 
GD100  ΔtolC - ftolCstart rygiCkan  
GD101  ΔygiBC - ftolCstart rygiCkan  
GD102  ΔtolC ΔygiBC - ftolCstart rygiCkan  
GD103 ΔyjfMC + yjfMC  fyjfL rygiCkan 1800 
GD104  ΔygiBC ΔyjfMC + yjfMC  fyjfL rygiCkan 1800 
GD105  ΔtolC ΔygiBC 
ΔyjfMC 
+  yjfMC  fyjfL rygiCkan 1800 
GD106  ΔspeE ΔtolC + tolC  k2 rygiA 1204 
GD107  ΔgshB ΔtolC + tolC  k2 rygiA 1204 
GD108  ΔygiBC ΔyjfMC 
ΔgspS 
+ gspS  k2 rPitB 1556 
GD109  ΔspeE ΔygiBC + ygiBC TolCS1 rygiCkan 1905 




GD111  ΔyjfMC ΔtolC + tolC  k2 rygiA 1204 
GD112  ΔgshA ΔtolC + tolC  k2 rygiA 1204 
GD113 MG1655 but 
ΔtolC 
+ tolC k2 rygiA 1204 
JW0117-1 ∆speE +  k2 rspeD 856 






JW2956-1 ∆gspS +  k2 rpitB 1556 




GD201 GD101 but 
TolCQ352C
his





GD202 GD101 but 
TolCD356C
his





GD203 GD101 but 
TolCS363C
his






















 in  
tolC-ygiBC locus 
start 
GD205 GD101 but 
TolC
his





GD206 GD201 but 
∆acrAB 
+ acrAB k2 rAcrABdownstr 1184  
GD207 GD202 but  
∆acrAB 
+ acrAB k2 rAcrABdownstr 1184 
GD208 GD204 but 
∆acrAB 




Appendix B. Growth rates of strains  
Growth medium  WT GD100 GD102 GD105 
M9 + CAA 0.76 ±0.16 0.96  ±0.03 0.83± 
0.06 
0.86 ±0.05 
M9 + Riboflavin 0.652 0.25 0.58 0.21 
M9 + Thiamine 0.628 0.40 0.47 0.21 
M9 + Aspartate 0.61 ND ND 0.57 
M9 + Glutamate 0.6 ±0.04 ND ND 0.38 ±0.16 
M9 + Methionine 0.58 ND ND 0.51 
M9 + 0.4g/L Alanine 1.2 ND ND 1.4 
M9 + Serine 0.54 ±0.03 ND ND 0.61± 0.042 
M9 + Glycine 0.66± 0.06 ND ND 0.36 ±0.085 
M9 + Glycerol 0.38± 0.05 0.41 ±0.007 ND 0.43± 0.07 
M9 + Fructose 0.46± 0.03 0.43 ±0.03 ND 0.42± 0.06 
M9 + Xylose 0.41± 0.03 0.41± 0.04 ND 0.41 ±0.007 







ND 0.59 0.58 0.49±0.05 
LB +5 mM GSH 1.0 ± 0.09 0.97 ND 0.98±0.05 
LB + 10  mM GSH 0.87±0.1 0.65 ND 0.53±0.07 
LB + 15 mM GSH 0.64±0.07 No growth ND No growth 
LB + 1 mM  
L-cys 







ND- not determined 
 
Appendix C. List of primers 
 
Primer name Sequence 5’→3’ 
fTolCKana ATC GGC CTG AGC CTT TCT GGG TTC AGT  TCG TTG 
AGC TGT GTA GGC TGG AGC TGC TT  
rTolCKana CGG TTT GCT CAG CGC ATT GTT CTG TCC CCA GAG 
CTG ACC ATA TGA ATC CTC CTT AG 
K2  CGG TGC CCT GAA TGA ACT GC 
TolC start AAT GCA AAT GAA GAA ATT GC 
ftolcstart AGT TTG ATC GCG CTA AAT ACT GCT TCA CCA CAA 
GGA ATG CAA ATG AAG AAA TTG CT 
rtolC TAC GTT CAG ACG GGG CCG AAG CCC CGT CGT 
CGT CAT CAG TGG TGG TGG TGG TGG TG 
rtolChis2 TAC GTT CAG ACG GGG CCG AAG CCC CGT CGT 
CGT CAT CAG TGG TGG TGG TGG TGG TGG TTA 
LB + 5 mM  
L-cys 
1.2 1.17 ND 1.12 





rygiA TGG CTG GTC GAA ATT GAA GC 
fygiAkan GCT TCG GCC CCG TCT GAA CGT AAG GCA ACG 
TAA AGA TGT GTA GGC TGG AGC TGC TT 
rygiCkan ATA TGT GGA TAA AAC CGA GAC ATA TCC TGG 
GTG ATC CAT ATG AAT ATC CTC CTT AG 
fygiBkan AGA GTG ATG AAA CAG TGT CTC TCT ATC AAA 
ATG CTG TGT GTA GGC TGG AGC TGC TT 
fyjfMkan AAC AGT AAA ATT GGT CAC GGA GCG ATT AGT 
CGC ATT TGT GTA GGC TGG AGC TGC TT 
ryjfCkan CAA TCT GCG GTT TCT CGC CAT CGA ACC AGG ACG 
CAA CAT ATG AAT ATC CTC CTT AG 
fyjfL GAG TAT TCC AGA CTA TTT CG 
raidB ACG GTG TGA GTT TGC CAG TG 
raid2 GCG CAA TAA TTC AGG CGG AT 
rYqgE CCA GCG GCT TGT TGA CGA TG 
ryqaA TGG CAC TAA TTG TAG GCC TGC AC 




rPitB  CGC AAT GAC CAG GCC GAC GA 
fRsmE GAT ATC CTG TTG GGA CCT CGC G 
LP gsp TAA TCA GTA CGG GGT TGC TAC 
RP gsp ACA ACA ATT ACG CCA ACT GCT TAG 
RygiBRT CAT CAT GTA ACC GGC CAT CAG 
yyqgE2 GGC CGT TAG CCA CGC GTT ATC 
rygiBRT#2 GTA TCA GCC ACC CAT TGA ACG 
rygiCRT GAT GTA GAG GAA CTC AGT AGC  
TolCD1 CAA AGC TCA TTA TGC GCG ATG GAA GCG 
TolCS2 CGC GTA CCG ACG CAG TAG CCC GCT TC  
fAcrABKanDisrptn TTT TGA CCA TTG ACC AAT TTG AAA TCG GAC ACT 
CGA GGT GTA GGC TGG AGC TGC TTC 
rAcrABKanDisrptn AGG CCG CTT ACG CGG CCT TAG TGA TTA CAC GTT 
GTA TCC ATA TGA ATA TCC TCC TTA G 
rAcrABdownstr ACT AAT ACC AGG ATT GCT CGT 
 
